|
EXHIBIT 2.1
EXECUTION
COPY
SHARE TRANSFER
AGREEMENT
BY AND
AMONG
DOLBY LABORATORIES,
INC.,
DOLBY SWEDEN HOLDING
AB,
THE SELLERS SET FORTH ON
SCHEDULE A ,
CIMON INVESTMENT MANAGERS
AB, AS SHAREHOLDER REPRESENTATIVE,
AND
U.S. BANK NATIONAL
ASSOCIATION, AS ESCROW AGENT
Dated as of
November 8, 2007
TABLE OF
CONTENTS
|
|
|
|
|
| |
|
Page |
| Article I DEFINITIONS |
|
3 |
|
|
|
| 1.1 |
|
Certain
Defined Terms |
|
3 |
| 1.2 |
|
Interpretations |
|
3 |
|
|
| Article II THE ACQUISITION |
|
4 |
|
|
|
| 2.1 |
|
Purchase
and Sale |
|
4 |
| 2.2 |
|
Purchase
Price |
|
4 |
| 2.3 |
|
The
Closing |
|
5 |
| 2.4 |
|
The
Second Closing |
|
5 |
| 2.5 |
|
Withholding Taxes and Tax Deposit Account |
|
6 |
| 2.6 |
|
Purchase
Price Adjustment and Post-Closing Procedures |
|
6 |
| 2.7 |
|
Escrow
Deposits & Payment Procedures |
|
12 |
| 2.8 |
|
Additional Adjustments to Purchase Price |
|
12 |
| 2.9 |
|
Company
Convertible Debenture Holder Obligations |
|
12 |
| 2.10 |
|
Warrant
Exercises |
|
13 |
| 2.11 |
|
SHA
Sellers |
|
13 |
|
|
| Article III REPRESENTATIONS AND WARRANTIES OF THE
SELLERS |
|
14 |
|
|
|
| 3.1 |
|
Organization of the Company; Authority |
|
14 |
| 3.2 |
|
Company
Capital Structure |
|
15 |
| 3.3 |
|
Subsidiaries |
|
16 |
| 3.4 |
|
No
Conflict |
|
18 |
| 3.5 |
|
Consents |
|
18 |
| 3.6 |
|
Company
Financial Statements |
|
18 |
| 3.7 |
|
Internal
Controls |
|
19 |
| 3.8 |
|
No
Undisclosed Liabilities |
|
20 |
| 3.9 |
|
No
Changes |
|
20 |
| 3.10 |
|
Accounts
Receivable |
|
24 |
| 3.11 |
|
Tax
Matters |
|
24 |
| 3.12 |
|
Restrictions on Business Activities |
|
27 |
| 3.13 |
|
Properties |
|
27 |
| 3.14 |
|
Intellectual Property |
|
28 |
| 3.15 |
|
Material
Contracts |
|
34 |
| 3.16 |
|
Interested Party Transactions |
|
37 |
| 3.17 |
|
Governmental Authorization |
|
37 |
| 3.18 |
|
Litigation |
|
38 |
| 3.19 |
|
Minute
Books |
|
38 |
| 3.20 |
|
Environmental Matters |
|
38 |
| 3.21 |
|
Brokers’ and Finders’ Fees; Third Party
Expenses |
|
38 |
| 3.22 |
|
Employee
Benefit Plans and Compensation |
|
39 |
-i-
TABLE OF
CONTENTS
(Cont’d)
|
|
|
|
|
| |
|
Page |
| 3.23 |
|
Insurance |
|
42 |
| 3.24 |
|
Compliance with Laws |
|
43 |
| 3.25 |
|
Export
Control Laws |
|
43 |
| 3.26 |
|
Anti-Bribery Law Compliance |
|
43 |
| 3.27 |
|
Substantial Customers and Suppliers |
|
43 |
| 3.28 |
|
Banks and
Brokerage Accounts |
|
44 |
| 3.29 |
|
Complete
Copies of Materials |
|
44 |
| 3.30 |
|
Representations Complete |
|
44 |
| 3.31 |
|
Ownership |
|
44 |
| 3.32 |
|
Authority |
|
45 |
| 3.33 |
|
Insolvency |
|
45 |
| 3.34 |
|
No
Conflict |
|
45 |
| 3.35 |
|
Absence
of Claims by the Sellers |
|
46 |
| 3.36 |
|
Litigation |
|
46 |
|
|
| Article IV REPRESENTATIONS AND WARRANTIES OF PARENT AND
PURCHASER |
|
46 |
|
|
|
| 4.1 |
|
Organization |
|
46 |
| 4.2 |
|
Authority |
|
46 |
| 4.3 |
|
Consents |
|
47 |
| 4.4 |
|
Capital
Resources |
|
47 |
|
|
| Article V CONDUCT PRIOR TO THE CLOSING |
|
47 |
|
|
|
| 5.1 |
|
Affirmative Conduct of Business of the Company |
|
47 |
| 5.2 |
|
Restrictions on Conduct of Business of the Company |
|
48 |
| 5.3 |
|
Procedures for Requesting Purchaser Consent |
|
50 |
| 5.4 |
|
No
Solicitation |
|
51 |
|
|
| Article VI ADDITIONAL AGREEMENTS |
|
52 |
|
|
|
| 6.1 |
|
Access to
Information |
|
52 |
| 6.2 |
|
Notification of Certain Matters |
|
53 |
| 6.3 |
|
Confidentiality |
|
53 |
| 6.4 |
|
Public
Disclosure |
|
53 |
| 6.5 |
|
Commercially Reasonable Best Efforts to Complete |
|
53 |
| 6.6 |
|
Regulatory Approvals |
|
54 |
| 6.7 |
|
Contract
Consents, Amendments and Terminations |
|
55 |
| 6.8 |
|
Pre-Closing Employee Matters |
|
56 |
| 6.9 |
|
Post-Closing Employee Matters |
|
56 |
| 6.10 |
|
Expenses |
|
56 |
| 6.11 |
|
Allocation Certificate |
|
57 |
| 6.12 |
|
Further
Assurances |
|
57 |
| 6.13 |
|
Minority
Holders |
|
57 |
-ii-
TABLE OF
CONTENTS
(Cont’d)
|
|
|
|
|
| |
|
Page |
| 6.14 |
|
Specified
GAAP Financials |
|
58 |
| 6.15 |
|
Obligations of Purchaser |
|
58 |
| 6.16 |
|
Discharge
of Directors’ Liability |
|
58 |
| 6.17 |
|
Indemnification Insurance |
|
58 |
| 6.18 |
|
Updates
to Certain Schedules |
|
58 |
|
|
| Article VII CONDITIONS TO THE ACQUISITION |
|
59 |
|
|
|
| 7.1 |
|
Conditions to Obligations of Each Party to Effect the
Acquisition |
|
59 |
| 7.2 |
|
Conditions to the Obligations of Purchaser |
|
59 |
| 7.3 |
|
Conditions to Obligations of the Sellers |
|
62 |
| 7.4 |
|
Closing
Deliveries |
|
62 |
| 7.5 |
|
Closing
Deliverables and Second Closing |
|
64 |
|
|
| Article VIII SURVIVAL; INDEMNIFICATION; ESCROW
ARRANGEMENTS |
|
65 |
|
|
|
| 8.1 |
|
Survival |
|
65 |
| 8.2 |
|
Indemnification |
|
65 |
| 8.3 |
|
Indemnification Limitations |
|
67 |
| 8.4 |
|
No
Indemnification Limitations |
|
69 |
| 8.5 |
|
Indemnification Claims Procedures |
|
69 |
| 8.6 |
|
Third-Party Claims |
|
71 |
| 8.7 |
|
Escrow
Arrangements |
|
73 |
| 8.8 |
|
The
Shareholder Representative |
|
77 |
| 8.9 |
|
Seller
Release and Indemnity |
|
80 |
|
|
| Article IX TERMINATION, AMENDMENT AND WAIVER |
|
80 |
|
|
|
| 9.1 |
|
Termination |
|
80 |
| 9.2 |
|
Effect of
Termination |
|
81 |
| 9.3 |
|
Amendment |
|
82 |
| 9.4 |
|
Extension; Waiver |
|
82 |
|
|
| Article X GENERAL PROVISIONS |
|
82 |
|
|
|
| 10.1 |
|
Notices |
|
82 |
| 10.2 |
|
Counterparts |
|
84 |
| 10.3 |
|
Entire
Agreement |
|
84 |
| 10.4 |
|
No Third
Party Beneficiaries |
|
84 |
| 10.5 |
|
Assignment |
|
84 |
| 10.6 |
|
Severability |
|
84 |
| 10.7 |
|
Other
Remedies |
|
84 |
| 10.8 |
|
Governing
Law |
|
84 |
| 10.9 |
|
Consent
to Jurisdiction |
|
84 |
| 10.10 |
|
Waiver of
Jury Trial |
|
85 |
-iii-
TABLE OF
CONTENTS
(Cont’d)
|
|
|
|
|
| |
|
Page |
| Article XI APPENDIX A |
|
1 |
|
|
|
| 11.1 |
|
Defined
Terms |
|
1 |
-iv-
INDEX OF APPENDICES, EXHIBITS AND
SCHEDULES
|
|
|
| APPENDICES |
|
|
|
|
| Appendix A |
|
List of
Defined Terms |
|
|
| EXHIBITS |
|
|
|
|
| Exhibit A |
|
[
reserved ] |
| Exhibit B |
|
Form of
Director Resignation and Release Letter |
| Exhibit C |
|
Form of
Minority Holder Offer |
| Exhibit D |
|
Forms of
Legal Opinions of Counsel to the Company |
| Exhibit E |
|
Form of
Assignment Agreement |
|
|
| SCHEDULES |
|
|
|
|
| Schedule A |
|
Schedule of
Sellers |
| Schedule B |
|
Schedule of
Share Sellers and Allocation of Sellers’ Shares |
| Schedule C |
|
Schedule of
Warrant Sellers and Allocation of Seller Warrants |
| Schedule D |
|
Schedule of
Debenture Holders and Allocation of Company Convertible
Debentures |
| Schedule E |
|
Schedule of
Key Employees |
| Schedule F |
|
Schedule of
Assignment Agreement Signer |
|
|
| Schedule 2.2(a) |
|
Schedule of
Per Seller Purchase Price |
| Schedule 2.2(b) |
|
Schedule of
Per Seller Warrant Purchase Price |
| Schedule 2.5 |
|
Schedule of
Withholding Taxes |
| Schedule 6.10(a) |
|
Schedule of
Excluded Third Party Expenses |
| Schedule 6.10(b) |
|
Statement of
Expenses |
| Schedule 6.11 |
|
Allocation
Certificate |
| Schedule 7.2(d)(i) |
|
Schedule of
Third Party Contract Consents |
| Schedule 7.2(d)(ii) |
|
Schedule of
Third Party Contract Terminations and Modifications |
| Schedule 7.2(d)(iii) |
|
Schedule of
Third Party Contract Notice Requirements |
| Schedule 7.2(e) |
|
Schedule of
Individuals to Sign Proprietary Rights Agreements |
| Schedule 7.2(t) |
|
Confirmation
of Payment Arrangements for Certain of Service Providers Related to
Third Party Expenses |
| Schedule 7.4(a)(x) |
|
Schedule of
Agreements Incurring Obligations in Favor of Sellers |
| Schedule 8.2(a)(xii) |
|
Schedule of
Specified Contractual Liabilities |
| Schedule 8.3(d)(iv) |
|
Schedule of
Exclusions from Indemnification |
| Schedule 11.1(gg) |
|
Schedule of
Certain Customers |
| Schedule 11.1(bbbbb) |
|
Schedule of
Minority Holders |
| Schedule 11.1(nnnnnnn) |
|
Schedule of
Subsidiaries of the Company |
| Schedule 11.1(xxxxxx) |
|
Schedule of
Senior Managers |
-v-
SHARE TRANSFER
AGREEMENT
THIS SHARE TRANSFER AGREEMENT
(the “ Agreement ”) is made and entered
into as of November 8, 2007 by and among Dolby Laboratories,
Inc., a California corporation (“ Parent
”), Dolby Sweden Holding AB, a limited liability company
organized under the laws of Sweden (“ Purchaser
”) and a wholly owned subsidiary of Parent, CIMON Investment
Managers AB, as a representative of all shareholders of the Company
(the “ Shareholder Representative ”), the
Persons set forth on Schedule A hereto (each a “
Seller ” and collectively, the “
Sellers ”) and U.S. Bank National Association,
as Escrow Agent hereunder (the “ Escrow Agent
”). All capitalized terms that are used in this Agreement
shall have the respective meanings ascribed thereto in Article
I hereof.
RECITALS
A. As of the execution date
of this Agreement, Coding Technologies, AB, Reg.
No. 556542-4222, a company duly incorporated and organized
under the laws of Sweden, having its principal office at c/o
Advokatfirman Vinge KB, Box 1703, 111 87, Stockholm, Sweden (the
“ Company ”), has a share capital of SEK
1,179,462 divided into 11,794,620 outstanding shares (the “
Shares ”) and, on a fully diluted basis
(including all shares of Company Capital Stock issuable upon
exercise or conversion, as applicable, of the Company Warrants and
the Company Convertible Debentures), SEK 1,435,104 divided into
14,351,040 shares (the “ Fully Diluted Shares
”).
B. The Sellers listed on
Schedule B of this Agreement (the “ Share
Sellers ”) own 11,379,899 Shares in the Company (the
“ Sellers’ Shares ”), representing
96.5% of all registered shares in the Company. As of immediately
prior to the Closing Date, Schedule B shall be deemed to be
automatically updated, without any action by any of the parties, to
include the names of (i) all Other Sellers who have exercised
Seller Warrants or converted Company Convertible Debentures between
the date of this Agreement and the Closing Date and (ii) all
Minority Holders who, between the date of this Agreement and the
Closing Date, become signatories to this Agreement in order to sell
their Minority Shares (or have exercised Minority Warrants in order
to sell the resulting shares).
C. The Company has issued
warrants to subscribe for new shares (the “ Company
Warrants ”) a portion of which (hereinafter referred
to as the “ Seller Warrants ”) are held
by the Sellers listed on, and in the amounts as set forth on,
Schedule C of this Agreement (the “ Warrant
Sellers ”). As of immediately prior to the Closing
Date, Schedule C shall be deemed to be automatically
updated, without any action by any of the parties, (i) to
delete the names of all Warrant Sellers who have exercised Seller
Warrants between the date of this Agreement and the Closing Date
and (ii) to include the names of all Minority Holders who,
between the date of this Agreement and the Closing Date, become
signatories to this Agreement in order to sell their Minority
Warrants. Together, the Sellers’ Shares and Seller Warrants
represent 94.3% of the all Fully Diluted Shares.
D. The Company has issued
Company Convertible Debentures that are convertible into new shares
(such Company Convertible Debentures, together with the Seller
Warrants, the “ Other Securities ”) to
the Sellers listed on, and in the amounts as set forth on, Schedule
D of this Agreement (the “ Debenture Holders
” and, collectively with the Warrant Sellers, the “
Other
-1-
Sellers ”). As of
immediately prior to the Closing Date, Schedule D shall be
automatically updated, without any action by any of the parties, to
delete the names of all Debenture Holders who have converted
Company Convertible Debentures between the date of this Agreement
and the Closing Date.
E. Pursuant to the terms and
conditions of this Agreement, between the date of this Agreement
and the Closing Date, all Company Convertible Debentures shall be
converted into, and a portion of the Seller Warrants may be
exercised for, as applicable, new shares of the Company (which new
shares shall also be deemed to be Sellers’ Shares for
purposes of this Agreement and which Other Sellers shall be deemed
to be Share Sellers upon such exercise and/or conversion, as
applicable).
F. The Sellers listed on
Schedule B , Schedule C and Schedule D ,
collectively, represent more than ninety percent (90%) of all
Fully Diluted Shares.
G. The Share Sellers
(including the Debenture Holders and any Warrant Sellers who elect
to exercise Seller Warrants prior to Closing) wish to sell to
Purchaser, and Purchaser wishes to purchase from such Share
Sellers, 100% of the Sellers’ Shares (including those new
shares issuable upon exercise and/or conversion of such Other
Securities), and the Warrant Sellers who have elected not to
exercise Seller Warrants prior to Closing wish to sell to
Purchaser, and Purchaser wishes to purchase from such Warrant
Sellers, 100% of the unexercised Seller Warrants, all in exchange
for the consideration and on the terms and conditions otherwise set
forth herein (the “ Acquisition
”).
H. As a condition and
inducement to Purchaser to enter into this Agreement and incur the
obligations set forth herein, concurrently with the execution and
delivery of this Agreement, the individuals identified on
Schedule E (the “ Key Employees ”)
have executed retention bonus, non-competition and/or
non-solicitation agreements with the Company or the Company’s
German subsidiary, as applicable, effective upon the Closing (the
“ Key Employee Agreements ”).
I. As a condition and
inducement to Purchaser to enter into this Agreement and incur the
obligations set forth herein, prior to or concurrently with the
execution and delivery of this Agreement, the individual identified
on Schedule F has executed an Intellectual Property
Assignment Agreement with the Company, in substantially the form
attached as Exhibit E (the “ Assignment
Agreement ”).
J. A portion of the
consideration otherwise payable by Purchaser to the Sellers shall
be placed in escrow by Purchaser as security for the
indemnification obligations set forth in this Agreement.
K. The Sellers, on the one
hand, and Parent and Purchaser, on the other hand, each desire to
make certain representations, warranties, covenants and other
agreements in connection with the Acquisition.
NOW, THEREFORE, in
consideration of the mutual agreements, covenants and other
premises set forth herein, the mutual benefits to be gained by the
performance thereof, and for other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged and
accepted, the Parties hereto hereby agree as follows:
-2-
ARTICLE I
DEFINITIONS
1.1 Certain Defined
Terms . For all purposes of and under this Agreement,
capitalized terms not otherwise defined herein have the meanings
set forth in Appendix A .
1.2
Interpretations .
(a) When a reference is made
in this Agreement to an Exhibit or a Schedule, such reference shall
be to an Exhibit or a Schedule to this Agreement unless otherwise
indicated.
(b) When a reference is made
in this Agreement to an Article or a Section, such reference shall
be to an Article or a Section of this Agreement unless otherwise
indicated.
(c) The words
“include,” “includes” and
“including” when used herein shall be deemed in each
case to be followed by the words “without
limitation.”
(d) The headings set forth in
this Agreement are for reference purposes only and shall not affect
in any way the meaning or interpretation of this
Agreement.
(e) Unless otherwise
specifically provided or the context otherwise requires, all
references in this Agreement to the Company shall mean and refer to
the Company and its direct and indirect Subsidiaries.
(f) All references in this
Agreement to the Subsidiaries of a Person shall be deemed to
include all direct and indirect Subsidiaries of such
Person.
(g) Unless otherwise
specifically provided, all references in this Agreement to monetary
amounts or dollars shall mean and refer to United States
denominated dollars.
(h) The Parties hereto agree
that they have been represented by legal counsel during the
negotiation and execution of this Agreement and, therefore, waive
the application of any law, regulation, holding or rule of
construction providing that ambiguities in an agreement or other
document shall be construed against the Party drafting such
agreement or document.
(i) Words and phrases defined
or referred to in English law statutory provisions have the same
meanings when used in this Agreement.
-3-
ARTICLE II
THE
ACQUISITION
2.1 Purchase and
Sale .
(a) Sale of the
Sellers’ Shares .
(i) At the Closing and
subject to and upon the terms and conditions of this Agreement, the
Share Sellers will sell, transfer, convey and deliver to Purchaser
and Purchaser will purchase and acquire from the Share Sellers,
good and valid title to all of the Sellers’ Shares, free and
clear of all Liens and with full title guarantee.
(ii) Each of the Share
Sellers waives any rights of pre-emption that such Share Seller may
have in relation to any of the Sellers’ Shares and undertakes
to take all steps to ensure that any rights of pre-emption over any
of the Sellers’ Shares are waived prior to
Closing.
(b) Sale of the Seller
Warrants .
(i) At the Closing and
subject to and upon the terms and conditions of this Agreement, to
the extent any Seller Warrants have not been exercised as of
immediately prior to the Closing, the remaining Warrant Sellers
will sell, transfer, convey and deliver to Purchaser and Purchaser
will purchase and acquire from the remaining Warrant Sellers, good
and valid title to all of the Seller Warrants, free and clear of
all Liens and with full title guarantee.
(ii) Each of the Warrant
Sellers waives any rights of pre-emption that such Warrant Seller
may have in relation to any of the Seller Warrants and undertakes
to take all steps to ensure that any rights of pre-emption over any
of the Seller Warrants are waived prior to Closing.
2.2 Purchase
Price .
(a) Purchase Price for
the Sellers’ Shares . In consideration for the sale
of the Sellers’ Shares pursuant to Section 2.1(a)
hereof, upon the terms and subject to the conditions of this
Agreement, Purchaser shall pay to the Share Sellers for each
individual Share an amount determined as follows:
(X) (i) the Adjusted Purchase Price plus (ii) the
aggregate exercise price for any unexercised Seller Warrants
purchased pursuant to Section 2.2(b) of this Agreement
divided by (Y) the number of Fully Diluted Shares and
shall be referred to herein, and reflected on the Allocation
Certificate as, the “ Per Seller Share Purchase
Price ,” which amount shall be set forth in
Schedule 2.2(a) and in the Allocation
Certificate.
(b) Purchase Price for
the Seller Warrants . To the extent any Seller Warrants
have not been exercised as of immediately prior to the Closing
Date, in consideration for the sale of the remaining Seller
Warrants pursuant to Section 2.1(b) hereof, upon the
terms and subject to the conditions of this Agreement, Purchaser
shall pay to the Warrant Sellers for each Seller Warrant the
“ Per Seller Warrant Purchase Price ,”
which amount shall be determined as follows: the product of
(i) the number of new shares issuable upon exercise of such
Seller Warrant multiplied by (ii) the
-4-
difference of (X) the Per Seller
Share Purchase Price minus (Y) the exercise price per
share of such Seller Warrant. The Per Seller Warrant Purchase Price
shall be set forth in Schedule 2.2(b) and in the Allocation
Certificate.
2.3 The Closing
. Upon the terms and subject to the conditions of this Agreement,
the purchase of the Sellers’ Shares and the Seller Warrants
and the consummation of the other transactions contemplated by this
Agreement shall take place at a closing (the “
Closing ”), which shall take place as promptly
as practicable after the execution and delivery of this Agreement
and the documents and instruments as set forth herein, and
following the satisfaction or waiver of the conditions set forth in
Article VII hereof, at the offices of Wilson Sonsini
Goodrich & Rosati, Professional Corporation, 1301 Avenue
of the Americas, 40 th Floor, New York, NY 10019 and/or at the offices of
Advokatfirman Vinge KB, Smålandsgatan 20, SE-11187 Stockholm,
Sweden in respect of the Closing Deliverables under
Section 7.4 below. All documents delivered and actions
taken at the Closing shall be deemed to have been delivered or
taken place simultaneously, and no such delivery or action shall be
considered effective or complete unless or until all other such
deliveries and actions are completed or waived in writing by the
Party against whom such waiver is sought to be enforced. The date
upon which the Closing actually occurs shall be referred to herein
as the “ Closing Date
.”
2.4 The Second
Closing . In the event that any Minority Holders elect to
sell (or exercise and sell in the case of Company Warrants) any
Minority Shares and Warrants following the Closing Date, Purchaser
shall, upon the terms and subject to the conditions of this
Agreement, purchase the Shares and Company Warrants of such
Minority Holders at a second closing (the “ Second
Closing ”), which shall take place on the four
(4) week anniversary of the Closing Date at the offices of
Wilson Sonsini Goodrich & Rosati, Professional
Corporation, 1301 Avenue of the Americas, 40 th Floor, New York, NY 10019 and/or at the
offices of Advokatfirman Vinge KB, Smålandsgatan 20, SE-11187
Stockholm, Sweden in respect of the Closing Deliverables under
Section 7.4 below (it being understood that so long as
there is at least one Company Warrant outstanding as of the Second
Closing, Purchaser shall not be required to conduct the Second
Closing unless there is at least one Share remaining outstanding).
All documents delivered and actions taken at the Second Closing
shall be deemed to have been delivered or taken place
simultaneously, and no such delivery or action shall be considered
effective or complete unless or until all other such deliveries and
actions are completed or waived in writing by the Party against
whom such waiver is sought to be enforced. The date upon which the
Second Closing actually occurs shall be referred to herein as the
“ Second Closing Date .” Without any
further action on the part of the Sellers or Purchaser,
automatically upon the Second Closing, Schedule B and
Schedule C shall be deemed to be updated to include the
names of all Minority Holders who become signatories to this
Agreement between the Closing Date and the Second Closing Date in
order to sell their Minority Shares or Minority Warrants, as
applicable. Upon the Second Closing Date, each such selling
Minority Holder will be deemed to be a “Seller” for all
purposes of this Agreement and all representations and warranties
set forth in Section 3.31 to Section 3.36
shall be true and correct as of the Second Closing Date and all
other representations of the Sellers by such selling Minority
Holder shall be true and correct as of the Closing Date. Any
adjustments required to be made to the Tax Deposit Account, the
Escrow Fund, the Working Capital Escrow Fund or the Shareholder
Representative Distribution Account, as a
-5-
result of sales and purchases pursuant
to the Second Closing, shall be reflected in a revised Allocation
Certificate to be provided to Purchaser by the Shareholder
Representative no later than two (2) Business Days prior to
the Second Closing, and the Shareholder Representative shall make
all corresponding adjustments to such accounts immediately
following the Second Closing. The Shareholder Representative shall
be authorized to make such distributions to the Sellers who sold
Shares or Company Warrants in the Closing with respect to proceeds
otherwise payable to the Minority Holders selling their Minority
Shares or Minority Warrants in the Second Closing, to reflect the
Sellers’ pro rata portion of the Escrow Amount and
Working Capital Escrow Amount.
2.5 Withholding Taxes
and Tax Deposit Account . Purchaser shall be entitled to
deduct and withhold from any consideration payable pursuant to this
Agreement to any Seller, including any holder of Seller Warrants,
such amounts as may be required to be deducted or withheld under
any provision of applicable federal, local or foreign tax law or
under any applicable legal requirement, including, but not limited
to, any amounts required to have been withheld by the Company or
its Subsidiaries in connection with any Seller Warrants. At the
Closing, Purchaser shall deposit into an account (the “
Tax Deposit Account ”) an amount of cash
(deducted on an individualized basis from the portion of the
Adjusted Purchase Price otherwise payable to the Employee Warrant
Sellers) equal to the Tax Deposit Amount. Purchaser shall be deemed
to have deposited into the Tax Deposit Account, on behalf of each
Employee Warrant Seller such Employee Warrant Seller’s
portion of the Tax Deposit Amount as set forth in the Allocation
Certificate. To the extent any such amounts are so deducted,
withheld or deposited, such amounts shall be treated for all
purposes as having been paid to the Person to whom such amounts
would otherwise have been paid and Purchaser shall cause the
Company to remit such withheld funds to the appropriate taxing
authority. Schedule 2.5 sets forth all amounts to be
withheld from any consideration payable pursuant to this Agreement
to any holder of Seller Warrants.
2.6 Purchase Price
Adjustment and Post-Closing Procedures .
(a) Adjusted Purchase
Price by Company . At least five (5) calendar days
prior to the Closing Date, the Sellers shall cause the Company to
deliver to Purchaser (A) an unaudited consolidated balance
sheet of the Company estimated as of the Closing Date (the “
Company Closing Balance Sheet ”), (B) a
statement (the “ Company Closing Working Capital
Statement ”) of the Working Capital of the Company
estimated as of the Closing Date (“ Company Closing
Working Capital ”), which shall include a variance
analysis that summarizes and explains the changes reflected in the
Company Closing Balance Sheet from the Current Balance Sheet for
each balance sheet line item, and (C) the Company’s
calculation of the Net Cash, the Preliminary Company Working
Capital Adjustment Amount, the Estimated Adjustment Amount and the
Adjusted Purchase Price based upon the foregoing statements
prepared by the Company. The Sellers shall cause the Company
Closing Balance Sheet, the Company Closing Working Capital
Statement and the calculations based thereon to be certified by the
Chief Executive Officer and the Chief Financial Officer of the
Company as having been prepared in accordance with the principles
set forth below. The Sellers shall cause the Company Closing
Balance Sheet (x) to be prepared in accordance with GAAP
(except that the Company Closing Balance Sheet may omit footnotes
and other presentation items that may be required by GAAP) applied
consistently with respect to the
-6-
same accounting policies, practices and
procedures used to prepare the Financials and the Current Balance
Sheet, and (y) to fairly and accurately present the
Sellers’ good faith best estimate (based on reasonable
assumptions) of the balance sheet of the Company as of the Closing
Date. The Sellers shall cause the Company Closing Working Capital
Statement (x) except as set forth in the definition of
“Working Capital,” to be prepared in accordance with
GAAP applied consistently with respect to the same accounting
policies, practices and procedures used to prepare the Financials,
the Current Balance Sheet and the Company Closing Balance Sheet,
including without limitation, that all expenses have been recorded
in accordance with GAAP and all revenue has been recorded in a
manner consistent with the Year-End Financials and the Interim
Financials, and (y) to fairly and accurately present the
Company’s good faith best estimate (based on reasonable
assumptions) of the Company Closing Working Capital. Purchaser
shall have four (4) calendar days to review the
Company’s Closing Balance Sheet, Company’s Closing
Working Capital Statement and the attached calculations based
thereon, after which, unless reasonably objected by Purchaser, for
purposes of this Section 2.6 , the Company Closing
Balance Sheet and Company Working Capital Statement shall be
binding on the Parties hereto, subject to the terms of
Section 2.6(b) .
(b) Post-Closing
Purchase Price Correction By Purchaser . Purchaser shall,
within sixty (60) calendar days following the Closing Date
(the “ Correction Period ”), prepare (or
cause to be prepared) and delivered to the Shareholder
Representative (A) an unaudited consolidated balance sheet of
the Company as of the Closing Date (“ Purchaser Closing
Balance Sheet ”), (B) a statement (“
Purchaser Closing Working Capital Statement ”)
of Working Capital as of the Closing, which shall include a
variance analysis that summarizes and explains the changes
reflected in the Purchaser Closing Balance Sheet from the Current
Balance Sheet for each balance sheet line item, and
(C) Purchaser’s calculation of the “Adjusted
Purchase Price” based upon the foregoing statements prepared
by Purchaser and taking into account any changes in the amount of
“Net Cash” at Closing, as calculated by Purchaser, the
Purchaser Working Capital Adjustment Amount and the Purchaser
Closing Adjustment Amount (the “ Corrected Purchase
Price ”) (together with the Corrected Purchase Price,
the Purchaser Closing Balance Sheet and the Purchaser Closing
Working Capital Statement, referred to as “ Purchase
Price Adjustment Deliverables ”). The Purchaser
Closing Balance Sheet (x) shall be prepared in accordance with
GAAP (except that the Purchaser Closing Balance Sheet may omit
footnotes and other presentation items that may be required by
GAAP) applied consistently with respect to the same accounting
policies and procedures used to prepare the Financials, and
(y) shall fairly and accurately present Purchaser’s good
faith best estimate (based on reasonable assumptions) of the
balance sheet of the Company as of the Closing Date. The Purchaser
Closing Working Capital Statement (x) except as set forth in
the definition of “Working Capital,” shall be prepared
in accordance with GAAP applied consistently with respect to the
same accounting policies and procedures used to prepare the
Financials, including without limitation, that all expenses have
been recorded in accordance with GAAP, and all revenue has been
recorded in a manner consistent with the Year-End Financials and
(y) shall fairly and accurately present Purchaser’s good
faith best estimate (based on reasonable assumptions) of the
Company’s Working Capital at Closing.
-7-
(c) Final Closing
Purchase Price Correction Procedures .
(i) Review Period .
Within fifteen (15) Business Days following the Shareholder
Representative’s receipt of the Purchaser’s Purchase
Price Adjustment Deliverables (the “ Review
Period ”), the Shareholder Representative shall
notify Purchaser in writing if the Shareholder Representative
disagrees with any matters set forth within the Purchase Price
Adjustment Deliverables (the “ Notice of
Dispute ”). The Notice of Dispute shall set forth in
reasonable detail the basis for such dispute, the amounts involved
and the Shareholder Representative’s determination of any
disputed amounts. If no Notice of Dispute is received by Purchaser
within the Review Period, then (1) the Shareholder
Representative shall be deemed to have irrevocably consented and
agreed, for and on behalf of the Closing Date Company Sellers to
each item and amount set forth in the Purchase Price Adjustment
Deliverables and (2) the Purchase Price Adjustment
Deliverables shall become final and binding upon the parties in
accordance with Section 2.6(c)(iii) .
(ii) Consultation
Period . During the fifteen (15) Business Days immediately
following the delivery of a Notice of Dispute (the “
Consultation Period ”), the Shareholder
Representative and Purchaser shall seek in good faith to resolve
any differences that they may have with respect to the matters
specified in the Notice of Dispute, and any resolution in writing
by the Shareholder Representative and Purchaser as to any matter
specified in the Notice of Dispute shall be final, binding and
conclusive in accordance with Section 2.6(c)(iii)
.
(iii) Third Party
Review . If, at the end of the Consultation Period, Purchaser
and the Shareholder Representative have been unable to resolve any
differences that they may have with respect to the matters
specified in the Notice of Dispute, then the parties shall submit
all matters that remain in dispute with respect to the Notice of
Dispute (along with a copy of the Purchaser Closing Balance Sheet
and Purchaser Closing Working Capital Statement, marked to indicate
those line items that are not in dispute) to a nationally
recognized accounting firm that is mutually agreeable (such
agreement not to be unreasonably withheld or delayed) to both
Parties (the “ Independent Accounting Firm
”), which accounting firm shall not have provided accounting
services to any of Parent, Purchaser or the Company during the
three-year period immediately prior to its selection. In the event
Purchaser and the Shareholder Representative are unable to reach
agreement on the identity of the Independent Accounting Firm,
Purchaser shall select and Purchaser and the Shareholder
Representative shall engage one of the “big four”
accounting firms that has not provided audit services to either
Parent, Purchaser or the Company within two years of the date of
this Agreement. The Independent Accounting Firm shall resolve only
the matters specified in the Notice of Dispute upon which the
Shareholder Representative and Purchaser have been unable to agree
(including all items on the Purchaser Closing Balance Sheet and
Purchaser Closing Working Capital Statement that are affected by
the resolution of such disputed matters). The Independent
Accounting Firm, as soon as practicable after appointment, shall
consult with the Shareholder Representative and Purchaser. Each of
the Parties to this Agreement shall, and shall cause their
respective affiliates and representatives to, provide full
cooperation to the Independent Accounting Firm and each such Party
may submit a “position paper” to the Independent
Accounting Firm setting forth the position of such Party with
respect to any such disputed item or amount, which shall
be
-8-
considered by such Independent
Accounting Firm as it deems appropriate. The Independent Accounting
Firm shall (1) act in its capacity as an expert and not as an
arbitrator, (2) consider only those items and amounts as to
which there is a dispute between Purchaser and the Shareholder
Representative, and (3) be instructed to reach its conclusions
regarding any such dispute within fifteen (15) Business Days
after its appointment and provide a written explanation of its
decision, including its conclusions as to the appropriate amount of
each of the disputed matters in the Purchaser Closing Balance Sheet
and Purchaser Closing Working Capital Statement as to which the
Shareholder Representative and Purchaser disagree as set out in the
Notice of Dispute, and such decision shall be binding on the
parties to this Agreement in the absence of manifest error. With
respect to each disputed matter, such determination, if not in
accordance with the position of either Purchaser or the Shareholder
Representative shall not be in excess of the higher, nor less than
the lower, of the amounts advocated by the Shareholder
Representative in the Notice of Dispute or Purchaser in the
Purchaser Closing Balance Sheet and Purchaser Closing Working
Capital Statement with respect to such disputed matters. All
expenses relating to the engagement of the Independent Accounting
Firm (the “ Independent Accounting Firm
Expenses ”) shall be shared equally by Purchaser and
the Shareholder Representative on behalf of the Sellers, it being
understood and agreed that except as otherwise set forth in this
Agreement, any such expenses shall be borne by the Sellers directly
and shall not be deducted from the Escrow Amount or any funds of
Purchaser or the Company. The Independent Accounting Firm shall
determine all disputed item(s) and amount(s) and its decision in
respect thereof shall be final and binding upon Purchaser and the
Shareholder Representative and a copy of the final determination of
the Independent Accounting Firm shall be delivered to the Escrow
Agent. The closing balance sheet that is final and binding on the
Parties, as determined either through deemed acceptance pursuant to
Section 2.6(c)(i) , the agreement of the Parties
pursuant to Section 2.6(c)(ii) , or as determined by
the Independent Accounting Firm pursuant to this
Section 2.6(c)(iii) , is referred to as the “
Final Closing Balance Sheet ”. The amount of
Working Capital at Closing shall be referred to as the “
Final Closing Working Capital ”; the amount of
Net Cash at Closing shall be referred to as the “ Final
Closing Net Cash ”; and the adjustment amount at
Closing shall be referred to as the “ Final Closing
Adjustment Amount .”
(d) Actual Purchase
Price Adjustments and Special Escrow Fund .
(i) Closing Purchase Price
Negative Adjustment . In the event that the Estimated
Adjustment Amount as determined by the Company pursuant to
Section 2.6(a) is negative, then the Base Purchase
Price on the Closing Date shall be reduced by the full amount of
the absolute value of the Estimated Adjustment Amount (whether
positive or negative, the adjusted Base Purchase Price shall be
referred to as the “ Company Adjusted Base Purchase
Price ”).
(ii) Closing Purchase
Price Positive Adjustment; Creation of Special Escrow Fund . In
the event that the Estimated Adjustment Amount as determined
pursuant to Section 2.6(a) is positive, then on the
Closing Date, Parent or Purchaser shall deposit or cause to be
deposited an amount in cash equal to the Estimated Adjustment
Amount with the Escrow Agent, such deposit (together with interest
and other income thereon) to constitute the working capital escrow
fund (the “ Working Capital Escrow Fund
”); provided, however, that if the Estimated
Adjustment Amount exceeds the greater of (X) two million
dollars ($2,000,000) and (Y) twenty-five
-9-
percent (25%) of the Preliminary
Company Working Capital Adjustment Amount, then the amount of such
excess (the “ Threshold Adjustment Amount
”) shall be added to the Base Purchase Price on the Closing
Date and such sum shall be deemed to be the “Company Adjusted
Base Purchase Price” (such amount to be deposited in a
separate escrow being referred to as the “ Working
Capital Escrow Amount ”).
(iii) Purchase Price
Adjustment Payments .
(A) If the Base Purchase
Price is reduced pursuant to the adjustments set forth in
Section 2.6(d)(i) , then:
a) if the Final Closing
Adjustment Amount is less than Estimated Adjustment Amount, then on
the third Business Day following the determination of the Final
Closing Adjustment Amount, Purchaser and the Shareholder
Representative shall deliver to the Escrow Agent a joint
instruction instructing the Escrow Agent to release to Purchaser a
portion of the Escrow Fund equal to the full amount by which the
Estimated Adjustment Amount exceeds the Final Closing Adjustment
Amount (such amount, the “ Correction Amount
”) (for the avoidance of doubt, in such event Purchaser need
not comply with the provisions of Section 8.5 of this
Agreement governing indemnification procedures and the Correction
Amount shall not be subject to the Basket set forth in
Section 8.3 hereof); and
b) if the Final Closing
Adjustment Amount is greater than Estimated Adjustment Amount, then
on the Business Day following the determination of the Final
Closing Adjustment Amount, then Parent or Purchaser shall deliver
to the Shareholder Representative Distribution Account an aggregate
amount in cash equal to the full amount by which the Final Closing
Adjustment Amount exceeds the Estimated Adjustment Amount for
distribution to the Sellers in accordance with
Section 2.2 .
(B) If the Base Purchase
Price is not reduced pursuant to the adjustments set forth in
Section 2.6(d)(i) , then:
a) if the Final Closing
Adjustment Amount equals the Estimated Adjustment Amount, then on
the Business Day following the determination of the Final Closing
Adjustment Amount, Purchaser and the Shareholder Representative
shall deliver to the Escrow Agent a joint instruction instructing
the Escrow Agent to release the full Working Capital Escrow Fund to
the Shareholder Representative Distribution Account for
distribution to the Sellers in accordance with
Section 2.2 ; and
b) if the Final Closing
Adjustment Amount is greater than Estimated Adjustment Amount, then
on the Business Day following the determination of the Final
Closing Adjustment Amount:
i) Purchaser and the
Shareholder Representative shall deliver to the Escrow Agent a
joint instruction instructing the Escrow Agent to release the full
Working Capital Escrow Fund to the Shareholder Representative to
pay from the Shareholder Representative Distribution Account to the
Sellers in accordance with Section 2.2 ; and
-10-
ii) Parent or Purchaser shall
deliver to the Shareholder Representative Distribution Account an
aggregate amount in cash equal to the amount by which (x) the
Final Closing Adjustment Amount (less the Threshold Adjustment
Amount) exceeds (y) the Working Capital Escrow Fund for
distribution to the Sellers in accordance with
Section 2.2 ; and
c) if the Final Closing
Adjustment Amount is less than Estimated Adjustment Amount, then on
the Business Day following the determination of the Final Closing
Adjustment Amount, Purchaser and the Shareholder Representative
shall deliver to the Escrow Agent a joint instruction instructing
the Escrow Agent to release:
i) to Purchaser or Parent (as
Parent shall direct) that portion of the Working Capital Escrow
Fund equal to the full amount by which the Estimated Adjustment
Amount exceeds the Final Closing Adjustment Amount; and
ii) in the event the Working
Capital Escrow Fund is less than the full amount by which the
Estimated Adjustment Amount exceeds the Final Closing Adjustment
Amount, to Purchaser or Parent (as Parent shall direct) a portion
of the Escrow Fund equal to the amount by which such excess exceeds
the Working Capital Escrow Fund; and
iii) the amount, if any, by
which the Working Capital Escrow Fund exceeds the full amount by
which the Estimated Adjustment Amount exceeds the Final Closing
Adjustment Amount to the Shareholder Representative to pay from the
Shareholder Representative Distribution Account to the Sellers in
accordance with Section 2.2 .
(e) Purchase Price
Adjustment with respect to Pre-Closing Taxes . At least
five (5) calendar days prior to the Closing Date, the Sellers
shall cause the Company to deliver to Purchaser a statement (the
“ Company Tax Statement ”) setting forth
the Company’s good faith best estimate of the amount of
unpaid Pre-Closing Taxes (the “ Estimated Pre-Closing
Taxes ”). The Company Tax Statement shall be prepared
based on reasonable assumptions and in a manner consistent with the
past practices of the Company and its Subsidiaries in preparing
their Tax Returns, and shall be certified as having been so
prepared by the Chief Executive Officer and the Chief Financial
Officer of the Company. The Base Purchase Price deliverable by
Purchaser at Closing shall be reduced on a dollar-for-dollar basis
by the Estimated Pre-Closing Taxes. During the Correction Period,
Purchaser may, and in the event there is a difference between the
Preliminary Working Capital Adjustment Amount and the Final Closing
Working Capital Adjustment Amount, Purchaser shall, prepare (or
cause to be prepared), and delivered to the Shareholder
Representative a statement (the “ Purchaser Tax
Statement ”) setting forth Purchaser’s good
faith best estimate (based on reasonable assumptions and in a
manner consistent with the Company’s past practices, except
as otherwise required by applicable law) of the unpaid Pre-Closing
Taxes taking into account the tax impact of the difference in
revenue that may be reflected in the difference between the
Preliminary Working Capital Adjustment Amount and the Final Closing
Working Capital
-11-
Adjustment Amount; provided,
however, that the Purchaser Tax Statement shall not be
determinative of whether or not the Company has liability to a
Governmental Entity for any Pre-Closing Taxes. Any differences
between the Company Tax Statement and the Purchaser Tax Statement
shall be resolved in accordance with the procedures set forth in
Section 2.6(c) above, and the amount of unpaid
Pre-Closing Taxes as so determined shall be referred to as the
“ Adjusted Pre-Closing Taxes .” If the
Adjusted Pre-Closing Taxes exceed the Estimated Pre-Closing Taxes,
such excess may be offset against any payment by Parent, Purchaser
or the Escrow Agent for the benefit of the Sellers pursuant to
Section 2.6(d)(iii) , and any excess remaining
thereafter shall be released to Parent from the Working Capital
Escrow Fund or the Escrow Fund. If the Estimated Pre-Closing Taxes
exceed the Adjusted Pre-Closing Taxes, such excess shall be placed
in the Escrow Fund, and shall be governed by the terms of
Section 8.7 of this Agreement.
2.7 Escrow
Deposits & Payment Procedures .
(a) Escrow
Deposits . At the Closing, Purchaser shall deposit with the
Escrow Agent an amount of cash equal to the Escrow Amount, which
shall be deducted from the Adjusted Purchase Price otherwise
payable. Purchaser shall be deemed to have deposited with the
Escrow Agent, on behalf of each Seller such Seller’s pro
rata portion of the Escrow Amount, rounded to the nearest cent
(with amounts greater than or equal to $0.005 rounded up), as set
forth in the Allocation Certificate.
(b) Closing
Payments . At the Closing, Purchaser shall pay, or cause to
be paid, to the Shareholder Representative Distribution Account,
aggregate cash equal to (1) the Adjusted Purchase Price
minus (2) the sum of (w) the Escrow Amount plus
(x) the Working Capital Escrow Amount plus (y) the Tax
Deposit Amount plus (z) the Minority Holders Amount, allocated
as follows:
(i) for each Share Seller,
the Per Seller Share Purchase Price less such Share
Seller’s pro rata portion of the Escrow Amount (as
calculated and set forth in the Allocation Certificate);
and
(ii) for each Warrant Seller,
if any, the Per Seller Warrant Purchase Price less
(X) such Warrant Seller’s pro rata portion of the
Escrow Amount less (Y) such Warrant Seller’s
individual portion of the Tax Deposit Amount, if applicable (as
calculated and set forth in the Allocation Certificate).
2.8 Additional
Adjustments to Purchase Price . The per share amounts of
the Adjusted Purchase Price payable to holders of Company Capital
Stock, and any other applicable numbers or amounts, shall be
adjusted to reflect appropriately the effect of any stock split,
reverse stock split, stock dividend (including any dividend or
distribution of securities convertible into Company Capital Stock),
reorganization, recapitalization, reclassification or other like
change with respect to Company Capital Stock occurring or having a
record date on or after the date hereof and prior to the
Closing.
-12-
2.9 Company Convertible
Debenture Holder Obligations . The Company Convertible
Debentures, having the right to convert into 600,000 new shares of
Company Capital Stock, shall be converted by the holder of such
Company Convertible Debentures immediately prior or as soon as
practicable after the execution of this Agreement by (i) the
holder of the Company Convertible Debentures submitting written
requests to the Company for the conversion of the Company
Convertible Debentures, (ii) the Company via its bank ( Sw:
Emissionsinsitut ) instructing VPC to create interim shares, if
applicable, as well as new shares, and (iii) the Company
giving instructions to the Commissioner for Corporate Affairs (
Sw: Kommissionären för aktiebolagsärenden AB
) for the filing of the application documents with the Swedish
Companies Registration Office before Closing. The holder of such
Company Convertible Debentures shall use all commercially
reasonable efforts to procure that the conversion of the Company
Convertible Debentures is properly filed for registration by the
Swedish Companies Registration Office, that interim shares are
created in the VPC system, if applicable, that the new shares are
created by VPC in the VPC system and registered on the VPC account
or custody account of the holder of such Company Convertible
Debentures, as soon as possible after signing of this Agreement and
no later than the date that is immediately prior to the
Closing.
2.10 Warrant
Exercises . As soon as practicable after the execution of
this Agreement each holder of a Seller Warrant may exercise such
Seller Warrant by submitting a written request to the Company for
the exercise of such Seller Warrant and subscribing for the new
shares by signing a subscription list that the Sellers shall cause
the Company to prepare. Immediately after such actions are taken by
a holder of a Seller Warrant, the Sellers shall cause (i) the
Board of Directors of the Company to formally decide on the
allocation of the new shares based on the subscriptions made,
(ii) the Company, via its bank ( Sw: Emissionsinstitut
), to give instructions to VPC to create interim shares, if
applicable, as well as new shares, and (iii) the Company to
give instructions to the Commissioner for Corporate Affairs (
Sw: Kommissionären för aktiebolagsärenden AB
) for the filing of the application documents with the Swedish
Companies Registration Office before Closing. The Exercise Price of
the Seller Warrant will be paid to the Company on or before the
Closing by the holders of the Seller Warrant and the Company shall
make all withholdings and tax payments required with respect
thereto pursuant to Section 2.5 . Each of the holders
of such exercised Seller Warrants and the Sellers shall use all
commercially reasonable efforts to procure that the exercise of the
Seller Warrants is properly filed for registration by the Swedish
Companies Registration Office and that interim shares are created
in the VPC system, if applicable, that the new shares are created
by VPC in the VPC system and registered on the VPC account or
custody account of the holder of such Seller Warrants, as soon as
possible after signing of this Agreement and no later than the date
that is immediately prior to the Closing.
2.11 SHA
Sellers . Certain Sellers (the “ SHA
Sellers ”) are party, either as original signatories
or through accession, to a shareholders’ agreement executed
July 12, 2006 (the “ SHA ”). The SHA
provides for various rights and obligations between the SHA Sellers
regarding their Shares, convertible notes, and other equity
interests in the company, including, inter alia ,
preemption, “drag-along,” “tag-along” and
redemption rights. The SHA Sellers hereby waive and relinquish all
such rights they may have under the SHA, provided, however,
that this waiver and relinquishment shall be null and void ab
initio in the event that this Agreement is terminated in
accordance with its terms. Under such circumstances, the SHA shall
be treated by the SHA Sellers as if it had remained in effect with
no such waiver.
-13-
ARTICLE III
REPRESENTATIONS AND
WARRANTIES OF THE SELLERS
The Sellers hereby jointly and severally
represent and warrant to Purchaser and Parent, subject to such
exceptions as are specifically disclosed in the disclosure schedule
(referencing the appropriate section, subsection, paragraph and
subparagraph numbers, it being understood that such exceptions
shall qualify only the specific section, subsection, paragraph and
subparagraph referenced and any other section, subsection,
paragraph or subparagraph where it is reasonably clear upon a
reading of such disclosure without any independent knowledge on the
part of the reader regarding the matter disclosed that the
disclosure applies to such other section, subsection, paragraph or
subparagraph) supplied by the Sellers to Purchaser and Parent (the
“ Sellers’ Disclosure Schedule ”)
and dated as of the date hereof, on the date hereof and as of the
Closing, as though made at the Closing, as set forth in this
Article III ; provided that the representations and
warranties set forth in Section 3.31 through
Section 3.36 are made severally and not jointly by each
of the Sellers (and, with respect to the Sellers who sell their
Shares and Company Warrants at the Second Closing, such
representations and warranties as are set forth in
Section 3.31 through Section 3.36 shall be
made as of such Second Closing):
3.1 Organization of the
Company; Authority .
(a) The Company is duly
incorporated and validly existing under the laws of Sweden. The
Company has full corporate power and all necessary licenses,
permits and authorizations to carry on its business as now
conducted and to own, lease and operate the assets and properties
necessary in connection therewith. The Company is duly qualified or
licensed to do business and in good standing as a foreign
corporation in each jurisdiction in which the character or location
of its assets or properties (whether owned, leased or licensed) or
the nature of its business make such qualifications necessary. The
Company has delivered a true and correct copy of its articles of
association, as amended to date (the “ Articles of
Association ”) and in full force and effect on the
date hereof, to Purchaser. The Company Shareholders have not
approved or proposed any amendment to the Articles of Association
at a shareholders’ meeting or otherwise.
(b)
Section 3.1(b) of the Sellers’ Disclosure
Schedule lists the directors and Senior Managers of the Company and
its Subsidiaries as of the date hereof. None of such directors and
Senior Managers have any rights to indemnification from the Company
or any of its Subsidiaries. There are no other Employees of the
Company with similar or greater levels of responsibility or duties
within the Company or any of its Subsidiaries to those individuals
designated as Senior Managers or who have policy making authority.
The operations now being conducted by the Company are not now and
have never been conducted by the Company under any other
name.
(c)
Section 3.1(c) of the Sellers’ Disclosure
Schedule lists every state or foreign jurisdiction in which the
Company or any of its Subsidiaries has employees or facilities or
otherwise currently conducts any material portion of its
business.
-14-
(d) Each of the Company and
its Subsidiaries has full power and authority: (i) to conduct
its business in the manner in which its business is currently being
conducted; (ii) to own, lease and operate the assets held or
used by it and carry out its activities in the manner in which its
assets are currently owned, leased and used by it; and
(iii) to perform its obligations under all Contracts to which
it is a party or by which it is bound.
3.2 Company Capital
Structure .
(a) The authorized share
capital of the Company is SEK 1,179,462, divided into 11,794,620
ordinary shares, of which all 11,794,620 shares are issued and
outstanding as of the date of this Agreement. As of the date
hereof, the capitalization of the Company is as set forth in
Section 3.2(a)(i) of the Sellers’ Disclosure
Schedule. Assuming the same total capitalization as on the date
hereof, the total number of Shares outstanding as of immediately
prior to the Closing (assuming the exercise of all Company Warrants
and the conversion of all Company Convertible Debentures) will be
as set forth in Section 3.2(a)(i) of the Sellers’
Disclosure Schedule. The Shares are, as of October 25, 2007,
held of record by the Persons with the domicile or business
addresses and in the amounts set forth in the attached extract from
the VPC register, attached hereto as Section 3.2(a)(ii)
of the Sellers’ Disclosure Schedule, which further sets forth
for each such Person the number of shares held. For the purposes of
this Section 3.2(a) , the term “of record”
shall mean the persons set forth in the VPC register as of
October 25, 2007, and for the avoidance of doubt, exclusively
as of such date and not as of any other date. The Company has
issued Company Warrants to the Persons, and in the amounts, as set
forth in Section 3.2(a)(iii) of the Sellers’
Disclosure Schedule, which further sets forth for each such Person
the number of Company Warrants so issued and the applicable
exercise prices and expiration dates, and whether such Company
Warrant has been exercised. The Company has delivered to Parent and
Purchaser a true, correct and complete copy of the form of the
Company Warrant in the form attached to
Section 3.2(a)(iv) of the Sellers’ Disclosure
Schedule and each issued and outstanding Company Warrant is
identical in form (other than number of shares and exercise prices)
as the form of Company Warrant so delivered. To the Knowledge of
the Sellers, Section 3.2(a)(iii) of the Sellers’
Disclosure Schedule sets forth information regarding the beneficial
owners of the Company Warrants as of the Closing, including the
identity of such beneficial owners and the number of Company
Warrants owned by such owners. Each Company Warrant had, on the
date of grant, an exercise price of no less than the fair market
value of the shares of Company Capital Stock subject to such
Company Warrant. The Company has issued Company Convertible
Debentures to the Persons, and in the amounts, as set forth in
Section 3.2(a)(v) of the Sellers’ Disclosure
Schedule, which further sets forth for each such Person the
principal amount for each such Company Convertible Debenture,
interest accrued through the date of this Agreement, if any, and
the number of new shares of the Company issuable in respect of each
such Company Convertible Debenture. The Company has delivered true,
correct and complete copies of each issued and outstanding Company
Convertible Debenture to Parent and Purchaser. All outstanding
shares of Company Capital Stock are duly authorized, validly
issued, fully paid and non-assessable and are not subject to
preemptive rights created by statute, the Articles of Association,
or any agreement to which the Company is a party or by which it is
bound.
-15-
(b) All outstanding shares of
Company Capital Stock and all of the Company Warrants have been
issued or repurchased (in the case of shares that were outstanding
and repurchased by the Company or any Company Shareholder) in
compliance with all applicable federal, state, foreign, or local
statutes, laws, rules, or regulations, including federal and state
securities laws, and were issued, transferred and repurchased (in
the case of shares that were outstanding and repurchased by the
Company or any Company Shareholder) in accordance with any right of
first refusal or similar right or limitation known to the Company,
or properly waived or complied with. No shares of Company Capital
Stock or Company Warrants were issued to any individual that is a
resident or citizen of the United States or any entity with a
principal place of business or primary business address in the
United States. All Company Warrants are fully vested and
exercisable and not subject to any rights of repurchase or
forfeiture. The Company has not, and will not have, suffered or
incurred any liability (contingent or otherwise) or claim, loss,
liability, damage, deficiency, cost or expense relating to or
arising out of the issuance or repurchase of any Company Capital
Stock or options to purchase Company Capital Stock, or out of any
agreements or arrangements relating thereto (including any
amendment of the terms of any such agreement or arrangement. There
are no declared or accrued but unpaid dividends with respect to any
shares of Company Capital Stock. The Company has no other capital
stock authorized, issued or outstanding.
(c) There are no outstanding
loans to the board members, the managing director or any Senior
Manager or shareholder of the Company or to any board member,
managing director or officer of any of the Company’s
Subsidiaries.
(d) Neither the Company nor
any of its Subsidiaries has ever adopted, sponsored or maintained
any stock option plan or any other plan or agreement providing for
equity compensation to any Person. Except as set forth on
Section 3.2(a)(iii) and Section 3.2(a)(v)
of the Sellers’ Disclosure Schedule, there are no options,
warrants, calls, rights, convertible securities, commitments or
agreements of any character, written or oral, to which the Company,
or any of its Subsidiaries, is a party or by which the Company, or
any of its Subsidiaries, is bound obligating the Company or any of
its Subsidiaries, as the case may be, to issue, deliver, sell,
repurchase or redeem, or cause to be issued, delivered, sold,
repurchased or redeemed, any shares of the capital stock of the
Company or any of its Subsidiaries, or obligating the Company or
any of its Subsidiaries to grant, extend, accelerate the vesting
of, change the price of, otherwise amend or enter into any such
option, warrant, call, right, commitment or agreement. There are no
outstanding or authorized stock appreciation, phantom stock, profit
participation, or other similar rights with respect to the Company,
or any of its Subsidiaries. Except as contemplated hereby, to the
Knowledge of the Sellers, there are no voting trusts (other than
the SHA), proxies, or other agreements or understandings with
respect to the voting stock of the Company. There are no agreements
to which the Company or any of its Subsidiaries is a party relating
to the registration, sale or transfer (including agreements
relating to rights of first refusal, co-sale rights or
“drag-along” rights) of any Company Capital
Stock.
-16-
3.3
Subsidiaries .
(a)
Section 3.3(a) of the Sellers’ Disclosure
Schedule lists each entity (including, in the case of partnerships,
associations an joint ventures, the identity of the co-parties to
such entities) in which the Company owns any shares of capital
stock or any interest in, or controls, directly or indirectly, any
other corporation, limited liability company, partnership,
association, joint venture or other business entity, including but
not limited to the Company’s Subsidiaries set forth on
Schedule 11.1(nnnnnnn) .
(b) One hundred percent
(100%) of the share capital of each of the Company’s
Subsidiaries is solely owned, of record (where applicable) and
beneficially, by the Company. The Company’s German Subsidiary
is a German limited liability company (G esellschaft mit
beschränkter Haftung ) duly incorporated and validly
existing under the laws of Germany. The Sellers have delivered a
true and correct copy of the Company’s German
Subsidiary’s articles of association, as amended to date and
in full force and effect on the date hereof, to Purchaser. All
current matters and circumstances which have occurred prior to the
date hereof which are required to be registered with the commercial
registers of the Company’s German Subsidiary under German law
are shown in the excerpt from the commercial registers of the
Company’s German Subsidiary which is attached hereto as
Schedule 3.3(b) . The share capital of the Company’s
German Subsidiary is divided into one share in the nominal amount
of EUR 24,500 and one share in the nominal amount of EUR 500. Such
shares in the Company’s German Subsidiary have been validly
issued, are fully (vollständig und werthaltig) paid,
either in cash or in kind, and have not been (openly or concealed)
repaid, are non-assessable ( i.e., there are no obligations
pursuant to statutory laws or shareholder resolutions or otherwise
to make further contributions (in cash or in kind)) and free from
any Liens. There are no pre-emptive rights, rights of first
refusals, option rights or any other rights of third parties to
acquire any of the shares in the Company’s German Subsidiary.
The shares in the Company’s German Subsidiary are, further,
not subject to (i) trust agreement, silent partnership,
sub-participation agreements, voting agreements or similar
agreement or (ii) sale, contribution, or other contractual
arrangement creating an obligation to transfer or encumber or
otherwise create any Lien or right in respect of shares in the
Company’s German Subsidiary. There are no option rights,
pre-emption rights, subscription rights, conversion rights or
similar rights with regard to future shares in the Company’s
German Subsidiary, except for any such rights arising pursuant to
the applicable statutory provisions. No insolvency proceedings have
been applied for or commenced in relation to the Company’s
German Subsidiary nor have any enforcement proceedings been applied
for or commenced with respect to any assets of the Company’s
German Subsidiary. No circumstances exist which would justify an
application for, or the commencement of any insolvency proceedings
in relation to the Company’s German Subsidiary; in
particular, the Company’s German Subsidiary is neither
over-indebted or illiquid nor is illiquidity impending.
(c) Except as otherwise
provided in Section 3.3(a) of the Sellers’
Disclosure Schedule, neither the Company nor any of its
Subsidiaries has ever owned, beneficially or otherwise, any shares
or other securities of, or any direct or indirect equity interest
in, any entity.
-17-
(d) Neither the Company nor
any of its Subsidiaries has agreed, nor are any of them obligated,
to make any future investment in or capital contribution to any
Person or entity.
(e) Neither the Company nor
any of its Subsidiaries has any liability, indebtedness,
obligation, expense, claim, deficiency, guaranty or endorsement of
any type, whether accrued, absolute, contingent, matured, unmatured
or other (whether or not required to be reflected in financial
statements in accordance with GAAP) with respect to the entity set
forth on Section 3.3(e) of the Sellers’
Disclosure Schedule.
3.4 No Conflict
. The execution and delivery of this Agreement and any Related
Agreements, and the consummation of the transactions contemplated
hereby and thereby, will not conflict with or result in any
violation of or default under (with or without notice or lapse of
time, or both) or give rise to a right of termination,
cancellation, modification or acceleration of any obligation or
loss of any benefit under (any such event, a “
Conflict ”) (a) any provision of the
Articles of Association, as amended, (b) any Contract to which
the Company or any of its Subsidiaries is a party or by which any
of their respective properties or assets (whether tangible or
intangible) are bound, or (c) any judgment, order, decree,
statute, law, ordinance, rule or regulation applicable to the
Company or any of its Subsidiaries or any of their respective
properties or assets (whether tangible or intangible).
Section 3.4 of the Sellers’ Disclosure Schedule
sets forth all necessary consents, waivers and approvals of parties
to any Contracts as are required thereunder in connection with the
Acquisition, or for any such Contract to remain in full force and
effect without limitation, modification or alteration after the
Closing so as to preserve all rights of, and benefits to, the
Company and its Subsidiaries under such Contracts from and after
the Closing. Immediately following the Closing, the Company and its
Subsidiaries will be permitted to exercise all of their respective
rights under the Contracts without the payment of any additional
amounts or consideration other than ongoing fees, royalties or
payments which the Company or one of its Subsidiaries would
otherwise be required to pay pursuant to the terms of such
Contracts had the transactions contemplated by this Agreement not
occurred.
3.5 Consents .
No consent, notice, waiver, approval, order or authorization of, or
registration, declaration or filing with any court, administrative
agency or commission or other international, federal, state,
county, local or other foreign governmental authority,
instrumentality, agency or commission (each, a “
Governmental Entity ”) or any third party,
including a party to any agreement with the Company or its
Subsidiaries (so as not to trigger any Conflict), is required by,
or with respect to, the Company in connection with the execution
and delivery of this Agreement and any Related Agreements or the
consummation of the transactions contemplated hereby and thereby,
except for such consents, waivers, approvals, orders,
authorizations, registrations, declarations and filings which if
not obtained or made would not be material to the Company or
materially adversely affect the ability of the Parties hereto to
consummate the Acquisition within the time frame in which the
Acquisition would otherwise be consummated in the absence of the
need for such consent, waiver, approval, order, authorization,
registration, declaration or filing and (c) any required
notifications under the HSR Act and any material foreign antitrust
laws, as applicable.
-18-
3.6 Company Financial
Statements . Section 3.6 of the Sellers’
Disclosure Schedule sets forth (i) the audited consolidated
balance sheet of the Company and its Subsidiaries as of
December 31, 2006, and the related consolidated statements of
income, cash flow and shareholders’ equity for the 12-month
period then ended (the “ Year-End Financials
”), (ii) the unaudited consolidated balance sheet of the
Company and its Subsidiaries as of June 30, 2007 (the “
Balance Sheet Date ”), and the related
unaudited consolidated statements of income, cash flow and
shareholders’ equity for the six months then ended (the
“ Interim Financials ”), (iii) a
schedule of Company Indebtedness and (iv) a statement of
comprehensive income for the six month period ended June 30,
2007 and the twelve month period ended December 31, 2006
(together with the Interim Financials, the Year-End Financials and
the schedule of Company Indebtedness, collectively referred as the
“ Financials ,” with all such Financials
certified as true and accurate by the Company’s Chief
Financial Officer). The Financials are true and fair in all
material respects and have been prepared in accordance with GAAP
applied on a consistent basis throughout the periods indicated and
consistent with each other, including without limitation, that all
expenses have been recorded in accordance with GAAP and all revenue
has been recorded in a manner consistent with past practices
(except that the Interim Financials do not contain footnotes and
other presentation items that may be required by GAAP). The
Financials give a true and fair view of the consolidated financial
condition, operating results and cash flows of the Company and its
Subsidiaries as of the dates and during the periods indicated
therein, subject in the case of the Interim Financials to normal
year-end adjustments, which are not material in amount or
significance in any individual case or in the aggregate. The
Financials have been prepared in accordance with all applicable
legislation and all current accounting standards applicable to
Sweden. The unaudited consolidated balance sheet of the Company and
its Subsidiaries as of the Balance Sheet Date is referred to
hereinafter as the “ Current Balance Sheet
” and shall include an itemized statement of the
Company’s Working Capital as of the Balance Sheet Date
Neither the Company nor any of the Subsidiaries have filed (or have
had filed against it) any petition for its winding-up, is not
insolvent within the meaning of applicable laws, rules or
regulations or similar requirements, and has not made any
assignment in favor of its creditors, nor has any petition for
receivership or any administration order been presented in respect
of the Company or any of its Subsidiaries. Neither the Company nor
any of its Subsidiaries has initiated any proceedings with respect
to a compromise or arrangement with its creditors or for its
dissolution, liquidation or reorganization or the winding-up or
cessation of its business. No receiver or administrative receiver
or liquidator has been appointed in respect of the Company or any
of the Subsidiaries or any of its material assets.
3.7 Internal
Controls . The Company has established, and maintains,
adheres to and enforces a system of internal accounting controls
which are effective in providing assurance regarding the
reliability of financial reporting and the preparation of financial
statements in accordance with GAAP (including the Financials),
including procedures that (a) require the maintenance of
records that in reasonable detail accurately and fairly reflect the
transactions and dispositions of the assets of the Company and its
Subsidiaries, (b) provide assurance that transactions are
recorded as necessary to permit preparation of financial statements
in accordance with GAAP, and that receipts and expenditures of the
Company and its Subsidiaries are being made only in accordance with
appropriate authorizations of management and the Board of Directors
of the Company or its Subsidiaries, as applicable, and
(c) provide assurance regarding prevention or
timely
-19-
detection of unauthorized acquisition,
use or disposition of the assets of the Company or its
Subsidiaries. Neither the Company (including any Employee thereof)
nor the Company’s independent auditors has identified or been
made aware of (a) any significant deficiency or material
weakness in the system of internal accounting controls utilized by
the Company and its Subsidiaries, (b) any fraud, whether or
not material, that involves the Company management or other
Employees who have a role in the preparation of financial
statements or the internal accounting controls utilized by the
Company or its Subsidiaries or (c) any claim or allegation
regarding any of the foregoing.
3.8 No Undisclosed
Liabilities . Neither the Company nor any of its
Subsidiaries has any liability, indebtedness, obligation, expense,
claim, deficiency, guaranty or endorsement of any type, whether
accrued, absolute, contingent, matured, unmatured or other (whether
or not required to be reflected in financial statements in
accordance with GAAP), except for those which (a) have been
reflected in the Current Balance Sheet, (b) have arisen in the
Ordinary Course of Business since the Balance Sheet Date and prior
to the date hereof or (c) has arisen in the Ordinary Course of
Business since the date hereof and does not arise from a violation
of Article V hereof, or (d) is otherwise disclosed on
Section 3.8 of the Sellers’ Disclosure
Schedule.
3.9 No Changes
. Since the date of the Year-End Financials, there has not been,
occurred or arisen any:
(a) transaction by the
Company or its Subsidiaries except in the Ordinary Course of
Business;
(b) modifications, amendments
or changes to the Articles of Association or the charter of any of
its Subsidiaries;
(c) expenditure, transaction
or commitment exceeding $100,000 individually;
(d) payment, discharge,
waiver or satisfaction, in any amount in excess of $100,000 in any
one case of any claim, liability, right or obligation (absolute,
accrued, asserted or unasserted, contingent or otherwise of the
Company or its Subsidiaries), other than payments, discharges or
satisfactions in the Ordinary Course of Business of liabilities
reflected or reserved against in the Current Balance
Sheet;
(e) destruction of, damage
to, or loss of any material assets (whether tangible or
intangible), material business or material customer of the Company
or its Subsidiaries (whether or not covered by
insurance);
(f) employment dispute,
including (i) any claims made by Employees which individually
or in the aggregate are reasonably expected to be material to the
Company or any of its Subsidiaries; (ii) claims or matters
raised by any individual, Governmental Entity, or workers’
representative organization, bargaining unit or union, regarding,
claiming or alleging labor trouble, wrongful discharge, unfair or
wrongful dismissal, unlawful discrimination, breach of contract or
any other unlawful employment or labor practice or action with
respect to the Company or its Subsidiaries (whether or not such
allegedly unlawful practice or action is actually unlawful under
the laws of Sweden or any other jurisdiction); or (iii) any
facts or matters, to the Knowledge of the Sellers, likely to give
rise to a claim within the meaning of this
Section 3.9(f) ;
-20-
(g) adoption or change in
accounting methods or practices (including any change in
depreciation or amortization policies or rates) by the Company or
its Subsidiaries other than as required by GAAP or applicable
law;
(h) adoption of or change in
any election in respect of Taxes, adoption or change in any
accounting method in respect of Taxes, agreement or settlement of
any claim or assessment in respect of Taxes, or extension or waiver
of the limitation period applicable to any claim or assessment in
respect of Taxes;
(i) through the date of this
Agreement, revaluation by the Company or its Subsidiaries of any of
its assets (whether tangible or intangible), including writing down
the value of inventory or writing off notes or accounts
receivable;
(j) declaration, setting
aside or payment of a dividend or other distribution (whether in
cash, stock or property, and whether openly or concealed) in
respect of any Company Capital Stock or capital stock of any of the
Company’s Subsidiaries, or any split, combination or
reclassification in respect of any shares of Company Capital Stock
or capital stock of the Company’s Subsidiaries, or any
issuance or authorization of any issuance of any other securities
in respect of, in lieu of or in substitution for shares of Company
Capital Stock or shares of the Company’s Subsidiaries, or any
direct or indirect repurchase, redemption, or other acquisition by
the Company or any of the Company’s Subsidiaries of any
shares of Company Capital Stock or capital stock of the
Company’s Subsidiaries (or options, warrants or other rights
convertible into, exercisable or exchangeable therefor);
(k) except as required by
Contracts in effect as of the date hereof that have been disclosed
to Purchaser, (i) increase in or other change to the salary or
other compensation (including equity based compensation) payable or
to become payable by the Company or its Subsidiaries to any of its
respective Senior Managers, directors, employees or consultants, or
(ii) declaration, payment or commitment or obligation of any
kind for the payment (whether in cash or equity) by the Company or
its Subsidiaries of a severance payment, termination payment,
bonus, special remuneration or other additional salary or
compensation (including equity based compensation), in each case to
any of its respective Senior Managers, directors, Employees or
consultants; provided in all cases that the actions contemplated by
clauses (i) and (ii) are consistent with the terms
required by such Contracts;
(l) termination of any
Contract that would have been a Material Contract if such Contract
had been in effect as of the date of this Agreement;
(m) sale, lease or other
disposition of any of the material assets (whether tangible or
intangible) or properties of the Company or any of its
Subsidiaries, including the sale of any accounts receivable of the
Company or any of its Subsidiaries, or any creation of any security
interest in such assets or properties;
-21-
(n) loan by the Company or
any of its Subsidiaries to any Person (except for advances to
employees for travel and business expenses in the Ordinary Course
of Business), or purchase by the Company or any of its Subsidiaries
of any debt securities of any Person or amendment to the terms of
any outstanding loan agreement;
(o) incurring by the Company
or any of its Subsidiaries of any indebtedness (including Company
Indebtedness), amendment of the terms of any outstanding loan
agreement, guaranteeing by the Company or any of its Subsidiaries
of any indebtedness, issuance or sale of any debt securities of the
Company or any of its Subsidiaries or guaranteeing of any debt
securities of others, except for obligations to reimburse employees
for travel and business expenses and trade payables incurred in the
Ordinary Course of Business;
(p) waiver or release of any
right or claim of the Company or any of its Subsidiaries, including
any waiver, release or other compromise of any account receivable
of the Company or any of its Subsidiaries;
(q) commencement or
settlement of any lawsuit by the Company or any of its
Subsidiaries, the commencement, settlement, notice or, to the
Knowledge of the Sellers, threat of any lawsuit or proceeding or
other investigation against the Company or any of its Subsidiaries
or relating to any of their businesses, properties or assets, or
any reasonable basis for any of the foregoing;
(r) written or (to the
Knowledge of the Sellers) oral notice of any claim or potential
claim of ownership, interest or right by any person other than the
Company or any of its Subsidiaries of the Company Intellectual
Property owned by or developed or created by the Company or any of
its Subsidiaries or of infringement by the Company or any of its
Subsidiaries of any other Person’s Intellectual
Property;
(s) issuance, grant,
delivery, sale or purchase of, or proposal, Contract or agreement
to issue, grant, deliver, sell or purchase, by the Company, of
(i) any shares of Company Capital Stock or capital stock of
any of its Subsidiaries or securities convertible into, or
exercisable or exchangeable for, shares of Company Capital Stock or
capital stock of any of its Subsidiaries, or (ii) any
subscriptions, warrants, options, rights or securities to acquire
any of the foregoing, except for issuances of Company Capital Stock
or shares of capital stock of any of its Subsidiaries upon the
exercise of Company Warrants or any of the foregoing that is
described in Section 3.2 of the Sellers’
Disclosure Schedule;
(t) (i) sale, lease, license
(other than licenses to customers in the Ordinary Course of
Business and as otherwise permitted under this Agreement) or
transfer of any Company Intellectual Property or execution, or, in
any material respect, any modification or amendment, of any
agreement with any Person with respect to Company Intellectual
Property, or (ii) purchase or license of any material
Intellectual Property of a third party other than Shrink-Wrap Code
or execution, or, in any material respect, any modification or
amendment, of any agreement with respect to the material
Intellectual Property of a third party other than Shrink-Wrap Code,
(iii) agreement or modification or amendment of an existing
agreement with respect to the
-22-
development of any Intellectual Property
with a third party, or (iv) material change outside the
Ordinary Course of Business in pricing or royalties set or charged
by the Company or any of its Subsidiaries to its customers or
licensees or in pricing or royalties set or charged by Persons who
have licensed Intellectual Property to the Company or any of its
Subsidiaries;
(u) entering into any
material agreement or modification to any Contract pursuant to
which any other party thereto is or was granted marketing,
distribution, development, delivery, manufacturing or similar
rights with respect to any Company Products or Company Intellectual
Property;
(v) Company Material Adverse
Effect;
(w) purchase or sale of any
interest in real property, granting of any security interest in any
real property, entry into or renewal, amendment or modification of
any lease, license, sublease or other occupancy of any Properties
or other real property by the Company or any of its
Subsidiaries;
(x) acquisition by the
Company or any of its Subsidiaries of, or agreement by the Company
or any of its Subsidiaries to acquire by merging or consolidating
with, or by purchasing any assets or equity securities of, or by
any other manner, any business or corporation, partnership,
association or other business organization or division thereof, or
other acquisition or agreement to acquire any assets or any equity
securities that are material, individually or in the aggregate, to
the business of the Company or any of its Subsidiaries;
(y) grant by the Company or
any of its Subsidiaries of any severance or termination pay (in
cash or otherwise) to any Employee, including any officer, except
payments made pursuant to written agreements disclosed in the
Sellers’ Disclosure Schedule;
(z) adoption or amendment of
any Company Employee Plan, or execution or amendment of any
Employee Agreement with Senior Managers or in excess of $100,000
per annum in salary, excluding annual salary increases in the
Ordinary Course of Business in the case of non-Senior
Managers;
(aa) execution of any
strategic alliance, affiliate or joint marketing arrangement or
agreement by the Company or any of its Subsidiaries;
(bb) any action to accelerate
the vesting schedule of any Company Options;
(cc) hiring, promotion,
demotion or termination or other change to the employment status or
title of any Senior Managers, except as may be permitted under this
Agreement;
(dd) alteration of any
interest of the Company in any of its Subsidiaries or any
corporation, association, joint venture, partnership or business
entity in which the Company directly or indirectly holds any
interest;
-23-
(ee) cancellation, amendment
or renewal of any insurance policy of the Company or any of its
Subsidiaries, except in the Ordinary Course of Business;
(ff) issuance or agreement to
issue any refunds, credits, allowances or other concessions with
customers with respect to amounts collected by or owed to the
Company or any of its Subsidiaries in excess of $25,000
individually or $100,000 in the aggregate; or
(gg) agreement by the
Company, any of its Subsidiaries, or any Senior Manager,
consultant, or employee on behalf of the Company or any of its
Subsidiaries, to do any of the things described in the preceding
clauses (a) through (ff) of this Section 3.9
(other than negotiations with Purchaser and its representatives
regarding the transactions contemplated by this Agreement and any
Related Agreements).
3.10 Accounts
Receivable .
(a) The Company has made
available to Purchaser a list of all accounts receivable, whether
billed or unbilled, of the Company and its Subsidiaries as of the
Balance Sheet Date, together with an aging schedule (of only billed
accounts receivable) indicating a range of days elapsed since
invoice.
(b) All of the accounts
receivable, whether billed or unbilled, of the Company and its
Subsidiaries arose in the Ordinary Course of Business, are carried
at values determined in accordance with GAAP consistently applied,
are not subject to any valid set-off or counterclaim, do not
represent obligations for goods sold on consignment, on approval or
on a sale-or-return basis or subject to any other repurchase or
return arrangement and are collectible except to the extent of
reserves therefor set forth in the Current Balance Sheet or, for
receivables arising subsequent to the Balance Sheet Date, as
reflected on the books and records of the Company and any of its
Subsidiaries (which receivables are recorded in accordance with
GAAP consistently applied). No person has any Lien on any accounts
receivable of the Company or its Subsidiaries and no request or
agreement for deduction or discount has been made with respect to
any accounts receivable of the Company or its
Subsidiaries.
3.11 Tax
Matters .
(a) Definition of
Taxes . For the purposes of this Agreement, the term
“ Tax ”, “ Taxation
,” or, collectively, “ Taxes ”
shall mean (i) any and all taxes, assessments and other
charges, duties, impositions, installments and liabilities imposed
by or on behalf of any Governmental Entity, including taxes based
upon or measured by gross receipts, income, profits, sales, use and
occupation, capital and value added goods and services, ad valorem,
transfer, franchise, withholding, payroll, recapture, employment,
excise and property taxes as well as public imposts, fees and
social security charges (including health, unemployment,
workers’ compensation and pension insurance), together with
all interest, penalties and additions imposed with respect to such
amounts, and (ii) any liability for the payment of any amounts
of the type described in clause (i) of this
Section 3.11(a) as a result of being a member of an
affiliated, consolidated, combined or unitary group (including any
arrangement for group or consortium relief or similar arrangement)
(a “ Consolidated Group ”) for any
period.
-24-
(b) Tax Returns and
Audits .
(i) The Company and its
Subsidiaries have (a) prepared and timely filed all required
returns, estimates, amendments, information statements, elections,
forms, transfer pricing studies and reports, and any attachments,
appendices or addenda thereto (“ Returns
”) relating to any and all Taxes concerning or attributable
to the Company, its Subsidiaries or their respective operations,
and such Returns have been prepared and completed in accordance
with applicable law, (b) timely paid all Taxes required to be
paid, whether or not shown to be due on such Returns and
(c) all Tax records required to be maintained by the Company
or any of its Subsidiaries have been properly maintained and are up
to date.
(ii) The Company and its
Subsidiaries have paid or withheld with respect to their Employees
and other third parties and any related Person, all income Taxes,
social security charges and similar fees and other Taxes required
to be paid or withheld, and have timely paid any such withheld
Taxes over to the appropriate authorities.
(iii) There is no Tax
deficiency outstanding, assessed or proposed against the Company or
any of its Subsidiaries, nor has the Company or any of its
Subsidiaries executed any waiver of any statute of limitations on
or extending the period for the assessment or collection of any
Tax.
(iv) To the Knowledge of the
Sellers, no audit or other examination of any Return of the Company
or any of its Subsidiaries is presently in progress, nor has the
Company or any of its Subsidiaries been notified of any request for
such an audit or other examination.
(v) Neither the Company nor
any of its Subsidiaries has any liabilities for unpaid Taxes as of
June 30, 2007, which have not been accrued or reserved on the
Current Balance Sheet (for the avoidance of doubt the Current
Balance Sheet should for the purposes of this clause include all
Taxes for which the Company or its Subsidiaries would have been
liable had their financial year ended on June 30, 2007),
whether asserted or unasserted, contingent or otherwise and neither
the Company nor any of its Subsidiaries will be liable for any
additional Taxes pertaining to the period before December 31,
2006. Neither the Company nor any of its Subsidiaries has incurred
any liability for Taxes since the Balance Sheet Date other than in
the Ordinary Course of Business.
(vi) The Company has made
available to Purchaser or its legal counsel copies of all Returns
for the Company and its Subsidiaries filed for all periods since
its 2000 fiscal year.
(vii) There are (and
immediately following the Closing there will be as a result of the
transactions contemplated by this Agreement) no Liens on the assets
of the Company or any of its Subsidiaries relating to or
attributable to Taxes other than Liens for Taxes not yet due and
payable.
-25-
(viii) Neither the Company
nor any of its Subsidiaries (a) is or has ever been a member
of a Consolidated Group for income Tax purposes (other than a group
the common parent of which was the Company), (b) is currently
a party to any Tax sharing, indemnification or allocation
agreement, (c) has any liability for the Taxes of any person
(other than Company or any of its Subsidiaries) as a result of
being or ceasing to be included in a Consolidated Group as a
transferee or successor, by contract or agreement, by operation of
law or otherwise, except for liabilities for certain Taxes of
certain employees in connection with their employment by the
Company or its Subsidiaries or liabilities for property, sales and
use, occupancy or similar taxes under commercial agreements arising
in the Ordinary Course of Business and (d) has ever been a
party to any joint venture, partnership or other arrangement that
could be treated as a partnership for Tax purposes.
(ix) The tax basis of the
Company and its Subsidiaries in their assets for purposes of
determining future amortization and depreciation is accurately
reflected or derivable from the books and records of the Company
and its Subsidiaries.
(x) No adjustment relating to
any Return filed by the Company or any of its Subsidiaries has been
proposed formally or, to the Knowledge of the Sellers, informally
by any Tax authority to the Company or any of its Subsidiaries or
any representative thereof.
(xi) Neither the Company nor
any of its Subsidiaries has engaged in a “reportable
transaction” as set forth in Treasury Regulation
Section 1.6011-4(b), or any transaction that is the same or
substantially similar to one of the types of transactions that the
Internal Revenue Service has determined to be a Tax avoidance
transaction and identified by notice, regulation, or other form of
published guidance as a listed transaction, as set forth in
Treasury Regulation Section 1.6011-4(b)(2).
(xii) Neither the Company nor
any of its Subsidiaries has been subject to Tax in any jurisdiction
other than its country of incorporation or formation by virtue of
having a permanent establishment in that jurisdiction. No claim has
ever been made by any Governmental Entity that the Company or its
Subsidiaries is or may be subject to taxation in a jurisdiction
where the Company and its Subsidiaries do not file
Returns.
(xiii) Neither the Company
nor any of its Subsidiaries will be required to include any income
or gain or exclude any deduction or loss from taxable income as a
result of (a) any change in method of accounting prior to the
Closing Date, (b) closing agreement with any Tax Authority
executed prior to the Closing Date, (c) installment sale or
open transaction disposition prior to the Closing Date or
(d) prepaid amount received prior to the Closing
Date.
(xiv) The Company has
provided to Purchaser all documentation relating to, and is in full
compliance with all terms and conditions of, any Tax exemption, Tax
holiday or other Tax reduction agreement or order (“
Tax Incentive ”) with respect to the Company or
its Subsidiaries. The consummation of the transactions contemplated
by this Agreement will not have any adverse effect on the continued
validity and effectiveness of any such Tax Incentive.
-26-
(xv) The Company has in its
possession for the purpose of claiming any foreign Tax credits
official foreign receipts for any Taxes paid by it or any of its
Subsidiaries to any foreign Tax authorities.
(xvi) All transactions and
agreements entered into by the Company with any of its Subsidiaries
or any of the Sellers and all transactions and agreements entered
into by any of the Subsidiaries with the Company, any other
Subsidiary or any of the Sellers have been made on terms and
conditions which do not in any way deviate from what would have
been agreed between independent parties ( i.e. , on an
arm’s length basis).
(xvii) All losses for Tax
purposes incurred by the Company or any of its Subsidiaries are
operating losses and as of the Closing Date are available to be
carried forward and set off against income in succeeding periods
without limitation except for any such limitation imposed directly
as a result of the transactions contemplated by this Agreement, or
changes in applicable laws after the date of this
Agreement.
3.12 Restrictions on
Business Activities . There is no agreement
(non-competition or otherwise), commitment, judgment, injunction,
order or decree to which the Company or any of its Subsidiaries is
a party or otherwise binding upon the Company or its Subsidiaries
which has or may reasonably be expected to have the effect of
prohibiting or impairing any business practice of the Company or
any of its Subsidiaries, any acquisition of property (tangible or
intangible) by the Company or any of its Subsidiaries, the conduct
of business by the Company or any of its Subsidiaries, or otherwise
limiting the freedom of the Company or any of its Subsidiaries to
engage in any line of business or to compete with any person.
Without limiting the generality of the foregoing, neither the
Company nor any of its Subsidiaries has entered into any agreement
under which the Company or any of its Subsidiaries is restricted
from selling, licensing, manufacturing or otherwise distributing
any of its Technology or Company Products or from providing
services to customers or potential customers or any class of
customers, in any geographic area, during any period of time, or in
any segment of the market.
3.13 Properties
.
(a) Owned Real
Property . Neither the Company nor any of its
Subsidiaries owns or has previously owned any real
property.
(b) Leasehold
Properties .
(i)
Section 3.13(b) of the Sellers’ Disclosure
Schedule sets forth a list of all Properties that are leased or
otherwise occupied by the Company or any of its Subsidiaries other
than any freehold properties (referred to in this
Section 3.13 as (“ Leased
Properties ”), identifying the date of the agreement
by which such Properties are occupied (each a “
Property Lease ”), the location, parties, base
rent, term and any options to extend relating thereto, together
with such details applicable to any superior titles. The Company
and its Subsidiaries have paid their respective rents in full and
up to date and has observed and performed the covenants on the part
of the lessee and the conditions contained in any leases (which
expression includes underleases) under which the Leased Properties
are held and the last demands for rent (or receipts if issued) were
unqualified and all such leases are valid and in full force in
accordance with their respective terms.
-27-
(ii) All licenses, consents
and approvals required from the lessors and any superior lessors
under the Property Leases and from their respective mortgagees (if
any) have been obtained and the covenants on the part of the lessee
contained in such licenses, consents and approvals have been duly
performed and observed.
(iii) There are no notices,
negotiations or proceedings pending in relation to rent reviews nor
is any rent liable at the date hereof to be reviewed and time is
not of the essence in respect of any steps to be taken in the
conduct of rent reviews.
(iv) There is no obligation
to reinstate any of the Leased Properties by removing or
dismantling any alteration made to the same by the Company, any of
its Subsidiaries or any predecessor in title to the
Company.
(v) There is no outstanding,
unobserved or unperformed obligation necessary to comply with any
notice or other requirement given by the lessor under any Property
Leases.
(vi) There are no
circumstances which would entitle any such lessor to exercise any
powers of entry or take possession or which would otherwise
restrict the continued possession and enjoyment of the Leased
Properties. To the Knowledge of the Sellers, there are no
indications that any creditor of the lessor of the business
premises of the Company’s German Subsidiary in Nürnberg,
Germany, intends to enforce its rights against such lessor by
selling such business premises (or parts thereof) in a public
auction.
(vii) There are no laws,
statutes, regulations or orders now in existence and the Company
has not received notice of any laws, statutes, regulations or
orders that are under active consideration by any Governmental
Entity that could require the tenant of any Leased Properties to
make any expenditure in excess of $50,000 to modify or improve such
of the Leased Properties to bring it into compliance therewith.
Neither the Company nor any Subsidiary shall be required to expend
more than $50,000 in the aggregate under all Property Leases to
restore such Properties at the end of the term of the applicable
lease to the condition required under such lease (assuming the
conditions existing in such Leased Properties as of the date hereof
and as of the Closing).
3.14 Intellectual
Property .
(a)
Section 3.14(a) of the Sellers’ Disclosure
Schedule contains a complete and accurate list (by name and latest
version number) of: (A) all products, Software or service
offerings with an individual total sales volume larger than
$100,000 that have been sold, distributed, made commercially
available, provided or otherwise disposed of by or for the Company
or any of its Subsidiaries since January 1, 2003
(collectively, “ Company Products ”); and
(B) all products, Software or service offerings which the
Company or any of its Subsidiaries, as of the date hereof, plans to
sell, distribute, make commercially available, provide or otherwise
dispose of in the next twelve (12) months, including any
products or service offerings under development Patent licenses
granted by the Company or any of its Subsidiaries are not
considered Company Products.
-28-
(b)
Section 3.14(b) of the Sellers’ Disclosure
Schedule lists for each item of Company Intellectual Property which
constitutes Registered Intellectual Property solely or jointly
owned by, filed in the name of, or applied for, by the Company or
any of its Subsidiaries (the “ Company Registered
Intellectual Property ”); (i) an identification
( e.g., application or issuance number and title) of such
item and the jurisdiction in which each has been filed or applied
for, (ii) the prosecution status of such item ( e.g .,
application filed or issued), (iii) any proceedings or actions
before any court, tribunal (including the European Patent Office
(“ EPO ”) and the United Stated Patent
and Trademark Office (the “ PTO ”) or
equivalent authority anywhere in the world) related thereto (other
than regular proceeding associated with the prosecution of a
Patent), (iv) the names of any other person having an
ownership interest in, or ownership rights with respect to such
item; and (v) the co-owners of such item (if applicable). Each
item of Company Registered Intellectual Property is currently in
compliance with all applicable legal requirements (including
payment of filing, examination and maintenance fees and proofs of
use) and, to the extent issued, is subsisting, valid and
enforceable. Neither the Company nor any of its Subsidiaries has
taken or failed to take any action (including failure to disclose
any information) that would limit the validity, scope or
enforceability of any Patents that are Company Registered
Intellectual Property. All necessary documents and certificates
currently due for filing as of the date hereof in connection with
such Company Registered Intellectual Property have been filed with
the relevant patent, copyright, trademark or other authorities in
the United States or foreign respective jurisdictions, as the case
may be, for the purposes of maintaining such Registered
Intellectual Property. The Company and its Subsidiaries are not
currently claiming “small entity status” in the
application for or registration of any Registered Intellectual
Property with the PTO.
(c) No Company Intellectual
Property or Company Product is subject to any court, administrative
or other legal proceeding or outstanding decree, order, judgment or
settlement agreement or stipulation in such proceeding that
restricts in any manner the use, transfer, provision, sale or
licensing thereof by the Company or any of its Subsidiaries or may
affect the validity, use or enforceability of such Company
Intellectual Property or Company Products.
(d) In each case in which the
Company or any of its Subsidiaries has acquired or purported to
acquire ownership of any material Technology or material
Intellectual Property Right from any Person (other than Employees
or consultants whose agreements are disclosed in accordance with
Section 3.14(g) below), such transfer has been executed
by way of a valid and enforceable assignment in favor of the
Company or one of its Subsidiaries sufficient to irrevocably
transfer all rights in such Technology and Intellectual Property
Rights, and all such Contracts are listed in
Section 3.14(d) of the Sellers’ Disclosure
Schedule. In accordance with applicable laws and regulations, the
Company or one of its Subsidiaries has recorded each such
assignment of a Registered Intellectual Property Right assigned to
the Company or one of its Subsidiaries with the PTO or other
relevant Governmental Entity.
-29-
(e) Each item of Company
Intellectual Property is free and clear of any Liens except for
Permitted Liens (for the avoidance of doubt, a non-exclusive
license grant as such shall not constitute a Lien). All Company
Intellectual Property is, as of the date hereof, and, as of
Effective Time will be, owned (solely or together with the third
parties identified in Section 3.14(b) of the
Sellers’ Disclosure Schedule) by, or exclusively licensed to
the Company or its Subsidiaries and be fully transferable,
alienable or licensable without restriction and without payment of
any kind to any third party or any current or former Employee or
shareholder of the Company or any of its Subsidiaries.
(f) Neither the Company nor
any of its Subsidiaries has transferred ownership of, or granted
any exclusive license of, or exclusive right to use, or authorized
the retention of any exclusive rights to use or joint ownership of,
any Technology or Intellectual Property Right that is or was
Company Intellectual Property, to any other Person. No Person who
has licensed any Technology or Intellectual Property Rights to the
Company or any of its Subsidiaries has ownership rights in, or a
license to, improvements or modifications made by the Company or
any of its Subsidiaries in or to such Technology or Intellectual
Property Rights. Neither the Company nor any of its Subsidiaries
has allowed any material Intellectual Property Right that is or was
Company Intellectual Property to lapse or enter the public
domain.
(g)
Section 3.14(g) of the Sellers’ Disclosure
Schedule sets forth either (A) the material Intellectual
Property developed by third party contractors (other than
Employees) for the Company or one of its Subsidiaries, or
(B) the Contract pursuant to which such Intellectual Property
was developed; and to the extent legally possible under the laws of
the relevant jurisdiction, all such Intellectual Property has been
transferred to, and is owned by, the Company or its Subsidiaries.
All other Intellectual Property developed by or for the Company or
any of its Subsidiaries was created or developed by Employees of
the Company or of one of its Subsidiaries acting within the scope
of their employment, and has either (A) to the maximum extent
legally possible under the laws of the relevant jurisdiction been
assigned by such Employee to the Company or its Subsidiaries or,
(B) by operation of law or otherwise is owned by the Company
or its Subsidiaries. Each current or former Employee of the Company
or any of its Subsidiaries has signed the Company’s standard
form of Employee Proprietary Information Agreement substantially in
the form attached to Section 3.14(g) of the
Sellers’ Disclosure Schedule, and such agreement includes
enforceable terms pursuant to which all Technology and Intellectual
Property Rights developed by such Employees within the scope of
their employment or other duties to the Company or any of its
Subsidiaries are assigned or confirmed to have been assigned to the
Company or one of its Subsidiaries to the maximum extent permitted
by applicable law. Without limiting the forgoing, with respect to
any Intellectual Property created or developed by Employees of the
Company or of one of its Subsidiaries in Germany or Sweden, each of
the Company and the relevant Subsidiary has satisfied all relevant
laws and regulations with respect to employee Intellectual
Property, including those under the Swedish Act on Employment
Inventions (lag 1949:345) ( om rätten till arbetstagares
uppfinningar ) (the “ Swedish Act ”)
and/or under the German Act of Employment Inventions (
Arbeitnehmererfindungsgesetz ) (the “ German
Act ”), as the case may be, and made all necessary
payments to Employees to fully vest all such Intellectual Property
Rights in the Company or its Subsidiaries, as the case may be, to
the maximum extent permitted by applicable law.
Section 3.14(g) of the Sellers’ Disclosure
Schedule
-30-
lists all material inventions created by
an Employee of the Company or any of its Subsidiaries that is
subject to either the Swedish Act or the German Act. Each of the
Company’s and the Company’s German Subsidiary’s
Employees has granted the Company or such Subsidiary the unlimited,
irrevocable and exclusive right of use in respect of all Copyrights
acquired or authored by such Employee in connection with his or her
employment. The Company and its relevant Subsidiaries have at all
times, as applicable, (i) exercised its rights under the
Swedish Act on Employment Inventions (lag 1949:345) ( om
rätten till arbetstagares uppfinningar ) and/or the German
Act on Employment Inventions ( Arbeitnehmererfindungsgesetz
) or similar provision, if any, contained in the service or
employment agreements of its Employees and (ii) duly fulfilled
its obligations under such German Act and Swedish Act, and
contractual provisions, as applicable.
(h)
Section 3.14(h) of the Sellers’ Disclosure
Schedule identifies, for each Company Product, all material
Technology and Intellectual Property Rights, other than Company
Intellectual Property or essential patents with respect to a
standard practiced by such Company Product, that are embodied in,
incorporated into, practiced by, combined with or distributed in
conjunction with such Company Product, and for each such item of
Technology or Intellectual Property Rights, the In-License pursuant
to which the Company receives rights to such Technology or
Intellectual Property Rights.
(i) The operation of the
business of the Company (including the design, development, use,
import, licensing, marketing, manufacture, sale or distribution of
Company Products or Company Intellectual Property), has not, does
not and will not when conducted in substantially the same manner
following the Closing, infringe or misappropriate any Intellectual
Property Right of any Person, violate any right of any Person
(including any right to privacy or publicity), or constitute unfair
competition or trade practices under the laws of any jurisdiction.
Neither the Company nor any of its Subsidiaries has received notice
from any Person claiming that the Company or any of its
Subsidiaries infringes or misappropriates any Intellectual Property
Right of any Person, violates any right of any Person (including
any right to privacy or publicity) or constitutes unfair
competition or trade practices under the laws of any jurisdiction
(nor does the Company or the Sellers have Knowledge of any basis
therefor).
(j) Section 3.14(j) of
the Sellers’ Disclosure Schedule lists all Contracts in
effect as of the signing date of this Agreement to which the
Company or any of its Subsidiaries is a party that grants the
Company or any of its Subsidiaries a license, ownership rights, an
option to, or other rights in or to any Technology or Intellectual
Property Rights owned of a third Person or under which the Company
or any of its Subsidiaries receives material Intellectual
Property-related services related to Software or other Technology
(collectively, “ In-Licenses ”), other
than (A) Contracts pursuant to which the Company or any of its
Subsidiaries has received a license to commercially available
Software or other Technology for a one-time payment of less than
$100,000 or a royalty of less than $100,000 per year and which
Software or other Technology is not incorporated into a Company
Product, and (B) Contracts pursuant to which the Company or
any of its Subsidiaries has received a license to a third
party’s Intellectual Property Rights for less than $100,000
and where such Intellectual Property Rights are not being
sublicensed or re-licensed by the Company or any of its
Subsidiaries to third parties. Section 3.14(j) of the
Sellers’ Disclosure Schedule lists all
-31-
Contracts in effect as of the signing
date of this Agreement, to which the Company or any of its
Subsidiaries is a party under which the Company or any of its
Subsidiaries grants any third Person a license or other rights in
or to any Technology or Intellectual Property Rights or provides
any Intellectual Property-related service to any third Person
(collectively, “ Out-Licenses ”; together
with the In-Licenses, the “ IP Licenses
”) other than non-exclusive licenses to customers for Company
Products or Company Intellectual Property pursuant to a Standard
Form Agreement. Neither the Company nor any of its Subsidiaries is
in breach of, nor has the Company or any of its Subsidiaries failed
to perform under, any IP License and, to the Knowledge of the
Sellers, no other party to any such IP License Agreement is in
breach thereof or has failed to perform thereunder. All IP Licenses
will survive the Closing in full force and effect without the need
for approval by any Person. Without limiting the foregoing, to the
extent that any Intellectual Property Rights or Technology licensed
to the Company or any of its Subsidiaries by a third Person is used
in, or necessary to, the conduct of the business of the Company or
any of its Subsidiaries following the Closing in substantially the
same manner as such business was conducted prior to the Closing,
the Company or its Subsidiaries, as the case may be shall continue
to have, without the payment of any additional consideration, all
such rights and licenses to such Technology and Intellectual
Property Rights. The consummation of the transactions contemplated
by this Agreement will not violate nor result in the breach,
modification, termination or suspension of any IP
License.
(k) For the purposes of
clarity, IP Licenses do not include the Contracts set forth on
Section 3.14(k)(i) of the Sellers’ Disclosure
Schedule relating to the entity set forth on
Section 3.3(e) of the Sellers’ Disclosure
Schedule. The Intellectual Property set forth on
Section 3.14(k)(ii) of the Sellers’ Disclosure
Schedule is all of the material Intellectual Property in which both
(A) the Company or any of its Subsidiaries and (B) the
entity set forth on Section 3.3(e) of the
Sellers’ Disclosure Schedule hold any ownership interest or
other rights.
(l)
Section 3.14(l) of the Sellers’ Disclosure
Schedule lists all Contracts between the Company and/ or any of its
Subsidiaries and any other Person wherein or whereby the Company or
any of its Subsidiaries has agreed to, or assumed, any obligation
or duty to warrant, indemnify, reimburse, hold harmless, guaranty
or otherwise assume or incur any obligation or liability or provide
a right of rescission with respect to the infringement or
misappropriation by the Company or any of its Subsidiaries or such
other Person of the Intellectual Property Rights of any third party
on terms that are materially different to those set forth in the
Company’s Standard Form Agreement.
(m) There are no Contracts
(including any IP License) between the Company or any of its
Subsidiaries and any other Person with respect to any Technology or
Intellectual Property Rights, including under any IP License, under
which there is any material dispute regarding the scope of such
Contract, or performance under such Contract, including with
respect to any payments to be made or received by the Company or
any of its Subsidiaries thereunder.
(n) Neither the Company nor
any Subsidiary of the Company has made a claim, or initiated any
action against, or given any written or explicit oral notice to,
any third Person, alleging that such third Person is infringing or
misappropriating any Company Intellectual Property.
-32-
(o) The Sellers, the Company
and each of its Subsidiaries has taken all steps that are
reasonably required to protect the confidential information and
trade secrets of the Company or its Subsidiaries and their rights
therein and to protect the confidential information and trade
secrets provided by any other Person to the Company or any of its
Subsidiaries.
(p) Neither this Agreement
nor the transactions contemplated by this Agreement, will, as
result of any Contract to which the Company or any of its
Subsidiaries is a party, cause (i) the Company or any of its
Subsidiaries, Purchaser or any Purchaser Subsidiary to grant any
third Person any right to or with respect to any Technology or
Intellectual Property Right owned by, or licensed to, Purchaser or
any Purchaser Subsidiary (other than Company), (ii) the
Company or any of its Subsidiaries, Purchaser, or any Purchaser
Subsidiary to be bound by, or subject to, any non-compete or other
restriction on the operation or scope of their respective
businesses that they did not have prior to the Closing, or
(iii) the Company or any of its Subsidiaries, Purchaser or any
Purchaser Subsidiary to be obligated to pay any royalties or other
amounts to any third Person in excess of those payable by any of
them, prior to the Closing.
(q)
Section 3.14(q) of the Sellers’ Disclosure
Schedule lists all Standards Bodies in which Company or any of its
Subsidiaries has participated or is participating, or is, or has
been, a member. “ Standards Body ” means
any formal or informal organization, body or group which is engaged
in or which has, or is in the process of, setting, establishing or
promulgating any industry or product standards or the terms under
which Intellectual Property Rights will be licensed or established
any rules binding for members under which patents essential to the
practice of such standard must be licensed. Except with respect to
the Standards Bodies and other entities listed in
Section 3.14(q) of the Sellers’ Disclosure
Schedule, neither the Company nor any of its Subsidiaries is under
any obligation or duty, or is bound by any Contract, to license any
Company Intellectual Property under “FRAND,”
“RAND” or “RANDZ” terms.
(r)
Section 3.14(r) of the Sellers’ Disclosure
Schedule lists all Open Source incorporated in any Company Product
or other Technology distributed by the Company. No Company Product
or other Technology distributed by the Company is subject as a
whole to the terms of any Open Source License.
(s) All products sold,
licensed, leased or delivered by the Company or any of its
Subsidiaries to customers and all services provided by or through
the Company or any of its Subsidiaries to customers on or prior to
the Closing conform in all material respects to applicable
contractual commitments, express and implied warranties, service
level commitments, product specifications and product documentation
and to any representations made by the Company or any of its
Subsidiaries to their respective customers. Neither the Company nor
any of its Subsidiaries has pending liability (and, to the
Knowledge of the Sellers, there is no basis for any present or
future action, suit, proceeding, hearing, investigation, charge,
complaint, claim or demand against the Company or any of its
Subsidiaries giving rise to any liability relating to the foregoing
contracts) for replacement, repair or redelivery thereof or other
damages in connection therewith in excess of any reserves therefore
reflected on the Company Financial Statements. Copies of all
current and prior standard form agreements ( Ger: Allgemeine
Geschäftsbedingungen ) for the sale of Company
-33-
Products (collectively, “
Standard Form Agreements ”), are attached to
Section 3.14(s) of the Sellers’ Disclosure
Schedule, and neither the Company nor any of its Subsidiaries is in
material breach of, nor has the Company nor any of its Subsidiaries
failed to perform under, such agreements.
(t) No (i) government
funding; (ii) facilities of a university, college, other
educational institution or research center; or (iii) funding
from any Person (other than funds received in consideration for
Company Capital Stock) was used in the development of any Company
Intellectual Property in any manner which would limit the ability
of the Company to exploit such Company Intellectual Property or
which would give any other Person any rights to such Company
Intellectual Property or require further payment by Company or any
of its Subsidiaries to any other Person.
(u) No Company Intellectual
Property or Technology of the Company is held, or is required to be
held, in escrow for the benefit of any third Person.
(v) Neither the Company nor
any of its Subsidiaries has collected any personally identifiable
information from any third parties other than Employees and
customers, suppliers and equity holders of the Company, each in
their capacities as such. The Company and its Subsidiaries have
complied with all applicable laws (including all laws of the U.S.
and the E.U.) and its internal privacy policies relating to
(i) the privacy of users of their products and services and
all Internet websites owned, maintained or operated by the Company
or any of its Subsidiaries and (ii) the collection, storage
and transfer of any personally identifiable information collected
by the Company, its Subsidiaries or by third parties having
authorized access to the records of the Company or its
Subsidiaries. The execution, delivery and performance of this
Agreement complies with all applicable laws (including all laws of
the U.S. and E.U.) relating to privacy and with the Company’s
and its Subsidiaries’ privacy policies. Copies of all current
and prior privacy policies of the Company and its Subsidiaries,
including the privacy policies included in the Company’s
Internet website, are attached to Section 3.14(v) of
the Sellers’ Disclosure Schedule. Each such privacy policy
and all materials distributed or marketed by the Company or any of
its Subsidiaries have at all times made all disclosures to users or
customers required by applicable laws (including all laws of the
U.S. and E.U.), and none of such disclosures made or contained in
any such privacy policy or in any such materials have been
inaccurate, misleading or deceptive or in violation of any
applicable laws (including all laws of the U.S. and E.U.) in any
material respects.
3.15 Material
Contracts .
(a)
Section 3.15(a) of the Sellers’ Disclosure
Schedule sets forth a complete and accurate list of each of the
following Contracts to which the Company or any of its Subsidiaries
is a party or otherwise bound (any Contract of a nature described
below (whether or not set forth on the Sellers’ Disclosure
Schedule) to which the Company or any of its Subsidiaries is a
party or otherwise bound, being referred to herein, along with the
IP Licenses and any other Contract required to be listed under
Section 3.14 , as a “ Material
Contract ” and, collectively, as the “
Material Contracts ”):
(i) any employment,
contractor or consulting agreement, Contract with an employee or
individual consultant, contractor, or salesperson, any agreement,
Contract or
-34-
commitment to grant any bonus, severance
or termination pay (in cash or otherwise) to any employee, or any
contractor, consulting or sales agreement, Contract, or commitment
with a firm or other organization, excluding any non-Senior Manager
agreements with annual salary amounts of less than $100,000 entered
into in the Ordinary Course of Business under the terms and
conditions of the Company’s standard form of employment
agreement, the form of which has been delivered to Parent and
Purchaser;
(ii) any agreement or plan,
including any stock option plan, stock appreciation rights plan or
stock purchase plan, any of the benefits of which will be
increased, or the vesting of benefits of which will be accelerated,
by the occurrence of any of the transactions contemplated by this
Agreement or the value of any of the benefits of which will be
calculated on the basis of any of the transactions contemplated by
this Agreement;
(iii) any fidelity or surety
bond or completion bond;
(iv) any Property Lease and
any lease of personal property having annual rental payments in
excess of $50,000 individually;
(v) any agreement of
indemnification of third parties or guaranty of obligations of
third parties (other than indemnification provisions set forth in
the Company’s Standard Form Agreements where the
indemnification obligation or guarantee is limited to the amount
received by Company under such Contact);
(vi) any Contract or
commitment relating to capital expenditures for tangible assets and
involving future payments in excess of $100,000
individually;
(vii) any Contract or
commitment relating to the disposition or acquisition of assets or
any interest in any business enterprise outside the Ordinary Course
of Business;
(viii) any mortgages,
indentures, guarantees, loans or credit agreements, security
agreements or other agreements or instruments relating to the
borrowing of money or extension of credit;
(ix) any purchase order or
Contract for the purchase of materials involving in excess of
$100,000 individually;
(x) any Contracts that
contain “most favored nation” or other preferred
pricing provisions;
(xi) any dealer,
distribution, joint marketing, strategic alliance, affiliate or
development agreement;
(xii) any Contract or
commitment to alter the Company’s interest in any Subsidiary,
corporation, association, joint venture, partnership or business
entity in which the Company directly or indirectly holds any
interest;
-35-
(xiii) any sales
representative, original equipment manufacturer, manufacturing,
value added, remarketer, reseller, or independent software vendor,
or other agreement for use or distribution of the products,
technology or services of the Company or its
Subsidiaries;
(xiv) any nondisclosure,
confidentiality or similar agreement, other than those entered into
with employees or contractors, or any actual or prospective
customer or vendor in the Ordinary Course of Business;
(xv) with regard to the
Company’s German Subsidiary, any domination agreement
(Beherrschungsvertrag), profit and loss pooling agreement
(Gewinnabführungsvertrag) or other enterprise agreement
within the meaning of Sec. 291 et sq. German Stock Corporation Act
(Unternehmensvertrag i.S.v. §§ 291 ff AktG), joint
venture or other co-operation agreement, cash-pooling agreements,
silent partnership agreement ( stille Beteiligung ) or any
agreement under which a third party is entitled to the profits (or
parts thereof) of the Company’s German Subsidiary;
or
(xvi) any other Contract or
commitment that involves revenue or expenses in excess of $200,000,
throughout the life of the Contract up to and including
September 30, 2007, individually and is not cancelable without
penalty within 30 days.
(b) Each Material Contract to
which the Company or any of its Subsidiaries is a party or any of
its properties or assets (whether tangible or intangible) is
subject is a valid and binding agreement of the Company or any of
its Subsidiaries, enforceable against each of the Parties thereto
in accordance with its terms, except as limited by laws of general
application relating to bankruptcy, insolvency and the relief of
debtors, and is in full force and effect with respect to the
Company or any of its Subsidiaries and, to the Knowledge of the
Sellers, any other party thereto. The Company and its Subsidiaries
are in compliance with and have not materially breached, violated
or defaulted under, or received written (including, without
limitation, email) or explicit oral notice that they have breached,
violated or defaulted under, any of the terms or conditions of any
such Material Contract, nor to the Knowledge of the Sellers is any
party obligated to the Company or its Subsidiaries pursuant to any
such Material Contract subject to any breach, violation or default
thereunder, nor do the Sellers or the Company have Knowledge of any
event that with the lapse of time, giving of notice or both would
constitute such a breach, violation or default by the Company or
any such other party. True and complete copies of each Material
Contract (whether or not disclosed in the Sellers’ Disclosure
Schedule) have been delivered or made available to
Purchaser.
(c) The Company and its
Subsidiaries have fulfilled all material obligations required to
have been performed by the Company and its Subsidiaries prior to
the date hereof pursuant to each Material Contract to which the
Company or any of its Subsidiaries is a party or any of its
properties or assets (whether tangible or intangible) is bound, and
to the Knowledge of the Sellers or the Company, without giving
effect to the Acquisition, the Company or its Subsidiaries will
fulfill, when due, all of its obligations under such Material
Contracts that remain to be performed after the date
hereof.
-36-
(d) There are no, and neither
the Sellers nor the Company has any Knowledge of any threatened,
material disputes or disagreements with respect to any Material
Contract to which the Company or any of its Subsidiaries is a party
or any of their respective properties or assets (whether tangible
or intangible) is subject, other than routine collection matters in
the Ordinary Course of Business not involving any substantive
dispute.
(e) No royalties, fees,
honoraria, volume-based, milestone or other payments are payable by
the Company or its Subsidiaries to any Person by reason of the
ownership, use, sale, licensing, distribution or other exploitation
of any Intellectual Property relating to the conduct or operation
of the business of the Company or its Subsidiaries or the delivery
or provision of any products, services or rights delivered or
provided thereby or thereunder, except for paid-up obligations
relating solely to end-user operating systems and application
Software and commercial Software used in connection with the
Company’s infrastructure and workstations.
(f) Neither the Company nor
any of its Subsidiaries have granted any other Person any exclusive
right to manufacture, have manufactured, assemble, license,
sublicense or sell any Company Products or to provide the services
or proposed services of the business of the Company or any of its
Subsidiaries.
(g) Each Material Contract is
in written form and has been provided to Purchaser in its
entirety.
(h) Excluding the Company
Convertible Debentures, all outstanding Company Indebtedness may be
prepaid without penalty.
3.16 Interested Party
Transactions . No Senior Manager or director, and to the
Knowledge of the Sellers, no Company Shareholder (nor any ancestor,
sibling, descendant or spouse of any of such persons, or any trust,
partnership or corporation in which any of such persons has or has
had an interest) has or has had, directly or indirectly,
(a) any interest in any entity which furnished or sold, or
furnishes or sells, services, products, Technology or Intellectual
Property Rights that the Company or any of its Subsidiaries
furnishes or sells, or (b) any interest in any entity that
purchases from or sells or furnishes to the Company or any of its
Subsidiaries any goods or services, or (c) any interest in, or
is a party to, any Contract to which the Company or any of its
Subsidiaries is a party, except for any employment agreement or
other agreement or any confidentiality and invention assignment
agreement in favor of the Company that has been provided to
Purchaser; provided , however , that ownership of no
more than one percent (1%) of the outstanding voting stock of
a publicly traded corporation shall not be deemed to be an
“interest in any entity” for purposes of this
Section 3.16 . To the Knowledge of the Sellers and the
Company, there are no Contracts or commitments with regard to
contribution or indemnification between or among any of the Company
Shareholders.
3.17 Governmental
Authorization . Each consent, license, permit, grant or
other authorization (a) pursuant to which the Company or any
of its Subsidiaries currently operates or holds any interest in any
of its properties or (b) which is required for the operation
of the business of the Company or any of its Subsidiaries as
currently conducted or the holding of any such interest
-37-
(collectively, “ Company
Authorizations ”) has been issued or granted to the
Company or its Subsidiaries. The Company Authorizations are in full
force and effect and constitute all Company Authorizations required
to permit the Company and its Subsidiaries to operate or conduct
its business or hold any interest in its properties or
assets.
3.18 Litigation
. There is no action, suit, claim or proceeding of any nature
pending, or to the Knowledge of the Sellers, threatened, against
the Company, any of its Subsidiaries or any of their respective
properties (tangible or intangible) or any of their respective
Senior Managers or directors, nor to the Knowledge of the Sellers,
is there any reasonable basis therefor. There is no investigation
or other proceeding pending or, to the Knowledge of the Sellers,
threatened, against the Company, any of its Subsidiaries or any of
their respective properties (tangible or intangible) or any of
their respective Senior Managers or directors by or before any
Governmental Entity, nor to the Knowledge of the Sellers is there
any reasonable basis therefor. No Governmental Entity has at any
time challenged or questioned the legal right of the Company or any
of its Subsidiaries to conduct its operations as presently or
previously conducted. To the Knowledge of the Sellers, there is no
action, suit, claim or proceeding of any nature pending or
threatened, against any Person who has a contractual right or a
right pursuant to applicable law to indemnification from the
Company or any of its Subsidiaries related to facts and
circumstances existing prior to the Closing, nor are there any
facts or circumstances that would give rise to such an action,
suit, claim or proceeding.
3.19 Minute
Books . The minutes of the Company and its Subsidiaries
made available to Purchaser contain complete and accurate records
of all actions taken, and summaries of all meetings held, by the
Company Shareholders and its Subsidiaries’ shareholders, the
Board of Directors of the Company and its Subsidiaries (and any
committees thereof) since the time of incorporation. At the
Closing, the minute books and minutes of the Company and its
Subsidiaries will be in the possession of the Company or its
Subsidiaries, as the case may be.
3.20 Environmental
Matters . The Company and its Subsidiaries are in
compliance in all material respects with all Environmental Laws.
Neither the Company nor any of its Subsidiaries is aware of any
fact or circumstance which would reasonably be expected to result
in material liability to the Company or its Subsidiaries with
respect to Hazardous Materials or pursuant to Environmental Laws.
Neither the Company nor any of its Subsidiaries has any material
liability or obligation pursuant to Environmental Laws. Neither the
Company, nor any of its Subsidiaries has retained or assumed by
contract or operation of law any material liability or obligation
of any other Person under any Environmental Law.
3.21 Brokers’ and
Finders’ Fees; Third Party Expenses . The Company has
not incurred, nor will it incur, directly or indirectly, any
liability for brokerage or finders’ fees or agents’
commissions, fees related to investment banking or similar advisory
services or any similar charges in connection with the Agreement or
any transaction contemplated hereby, nor will Purchaser incur,
directly or indirectly, any such liability based on arrangements
made by or on behalf of the Company. The Company has not entered
into any arrangement for the payment of any Third Party Expenses,
other than on a time and materials basis. Except for Third Party
Expenses from the services providers listed on Schedule
7.2(t) , which service providers have agreed to not
seek
-38-
payments from the Company, Purchaser or
Parent (or any of such entities’ affiliates) for any Third
Party Expenses owing to such service providers, all other Third
Party Expenses have been previously paid.
3.22 Employee Benefit
Plans and Compensation .
(a) Schedule .
Except for those items set forth on Section 3.22(a)(ii)
and Section 3.22(h) of the Sellers’ Disclosure
Schedule, Section 3.22(a)(i) of the Sellers’
Disclosure Schedule contains an accurate and complete list of each
material Company Employee Plan, each Employee Agreement under each
Company Employee Plan, and each Employee Agreement.
Section 3.22(a)(ii) of the Sellers’ Disclosure
Schedule sets forth a table setting forth the redacted name,
position/title, date of hire, start of service/employment, fixed
monthly gross salary, any promised increases in fixed monthly gross
salary or in any other forms of remuneration (other than warrants
issued to such employees), and any other form of remuneration of,
and any special protection against dismissal enjoyed by each
employee of the Company or any of its Subsidiaries as of the date
hereof. Company Warrants issued to Employees are set forth in
Section 3.22(a)(iii) to the Sellers’ Disclosure
Schedule. To the Knowledge of the Sellers, no Employee listed on
Section 3.22(a)(ii) of the Sellers’ Disclosure
Schedule has verbally or in writing expressed the intention to
terminate his or her employment for any reason, other than in
accordance with the employment arrangements provided for in this
Agreement. The Company and its Subsidiaries are under no liability
to establish, maintain or contribute to any Company Employee Plan
in respect of any Employee in Sweden and Germany, and there are no
circumstances in which the Company or any of its Subsidiaries could
have any liability (whether or not legally enforceable) to
contribute to any Company Employee Plan in respect of any Employee
in Sweden and Germany.
(b) Independent
Contractor Schedule . Section 3.22(b) of the
Sellers’ Disclosure Schedule contains an accurate and
complete list of all Independent Contractors and Persons that have
a consulting or advisory relationship with the Company or its
Subsidiaries, including initial date of engagement, any renewals of
such engagement and the rate of compensation for such
engagement.
(c) Documents .
The Company has provided to Purchaser (i) correct and complete
copies of all documents embodying each Company Employee Plan and
each Employee Agreement including all amendments thereto, if any
(ii) all material correspondence to or from any Governmental
Entity relating to any Company Employee Plan, and
(iii) details of any discretionary practices which may have
led any person to reasonably expect additional benefits and details
of any discretionary increases to pensions in payment or deferment
granted in the three years prior to the date of this
Agreement.
(d) Employee Plan
Compliance . The Company and its Subsidiaries have
performed all obligations required to be performed by them under,
are not in default or violation of, and the Sellers have no
Knowledge of any default or violation by any other party to, any
Company Employee Plan, and each Company Employee Plan has been
established, maintained and administered in accordance with its
terms and conditions and in compliance with all applicable laws,
statutes, orders, rules and regulations. Furthermore, no Company
Employee Plan has unfunded liabilities, that as of the Effective
Time, will not be offset by insurance or fully accrued. There
are
-39-
no actions, suits or claims pending or,
to the Knowledge of the Sellers, threatened or reasonably
anticipated (other than routine claims for benefits) against any
Company Employee Plan (including, for the avoidance of doubt,
against the trustees or managers of an International Employee Plan)
or against the assets of any Company Employee Plan. Each Company
Employee Plan relating solely to Employees in the U.S. can be
amended, terminated or otherwise discontinued after the Closing in
accordance with its terms, without liability to Purchaser, the
Company or any of its Subsidiaries (other than ordinary
administration expenses). Unless prohibited and/or restricted by
mandatory law, including court established legal practice, no
condition exists that would prevent the Company, Purchaser or
Parent from terminating or amending any Employee Plan at any time
for any reason without liability to the Company or its Subsidiaries
(other than ordinary administration expenses or routine claims for
benefits). There are no audits, inquiries or proceedings pending
or, to the Knowledge of the Sellers, threatened by any other
Governmental Entity with respect to any Company Employee Plan.
Neither the Company nor any of its Subsidiaries is subject to any
penalty in relation to Tax with respect to any Company Employee
Plan under any applicable law. The Company has timely made all
contributions and other payments required by and due under the
terms of each Company Employee Plan.
(e) No Pension
Plan . No U.S. Subsidiary of the Company has ever
maintained, established, sponsored, participated in, or contributed
to, any U.S. Company Employee Plan which is subject to Title IV of
ERISA or Section 412 of the Code. Except under the applicable
statutory pension insurance, no pension or retirement scheme or
similar commitment or arrangement with any director or Employee of
the Company or its Subsidiaries exists or has been promised by the
Company or its Subsidiaries.
(f) No Post-Employment
Obligations . No Company Employee Plan or Employee
Agreement provides, or reflects or represents any contractual
liability to provide post-termination benefits of any kind, (it
being understood that payment of accrued paid time off or vacation
upon termination of employment shall not constitute a
post-employment obligation for purposes of this subsection (f)) to
any person for any reason, except as may be required by applicable
mandatory law, and neither the Company nor any of its Subsidiaries
has represented, promised or contracted (whether in oral or written
form) to any Employee (either individually or to Employees as a
group) or any other person that such Employee(s) or other person
would be provided with employee benefits, except to the extent
required by mandatory law and as set out in Company Employee Plans
applicable to the Employees of the Company and its
Subsidiaries.
(g) Effect of
Transaction . Neither the execution and delivery of this
Agreement nor the consummation of the transactions contemplated
hereby will (i) result in any obligation being incurred by the
Company or any of its Subsidiaries to any Employee or Independent
Contractor, nor in any payment (including severance, golden
parachute, bonus or otherwise), becoming due to any Employee or
Independent Contractor, (ii) result in any forgiveness of
indebtedness, (iii) materially increase any benefits otherwise
payable by the Company or any of its Subsidiaries or
(iv) result in the acceleration of the time of payment or
vesting of any such benefits.
-40-
(h) Parachute
Payments . There is no agreement, plan, arrangement or
other Contract covering any Employee that, considered individually
or considered collectively with any other such agreements, plans,
arrangements or other Contracts, will, or could reasonably be
expected to, give rise directly or indirectly to the payment of any
amount that would be characterized as a “parachute
payment” under U.S. law or any compensation or severance
payment based on a contractual right. There is no agreement, plan,
arrangement or other Contract by which the Company or any of its
Subsidiaries is bound to compensate any Employee for excise taxes
paid, or for any other taxes payable by any Employee, including any
tax or employee national insurance payable in Sweden or
Germany.
(i) Employment
Matters . The Company and each of its Subsidiaries are in
compliance in all material respects with all applicable foreign and
local laws, rules and regulations and the Company’s and its
Subsidiaries’ own policies, plans or practices respecting
employment, employment practices, terms and conditions of
employment, worker classification, employee safety and health and
wages and hours and employment pension programs and plans, and in
each case, with respect to employees: (i) have withheld and
reported all amounts required by law or by agreement to be withheld
and reported with respect to wages, salaries and other payments to
employees, except with respect to amounts that may need to be
withheld in connection with the exercise of the Company Warrants,
which have not occurred as of the date of this Agreement, but for
which proper withholding and reporting will occur upon such
exercise, provided, for the avoidance of doubt, that such exercise
is made prior to the Effective Time, (ii) are not liable for
any arrears of wages, severance pay or any Taxes or any penalty for
failure to comply with any of the foregoing, and (iii) are not
liable for any payment to any trust or other fund governed by or
maintained by or on behalf of any governmental authority, with
respect to unemployment compensation benefits, social security or
other benefits or obligations for employees (other than routine
payments to be made in the Ordinary Course of Business including
routine payments and contributions provided by mandatory law, in
particular social insurance law). There are no actions, suits,
claims or administrative matters pending, or to the Knowledge of
the Sellers, threatened in writing against the Company, its
Subsidiaries or any of their respective employees relating to any
employee or Employee Agreement. There are no pending or, to the
Knowledge of the Sellers, threatened claims or actions against the
Company, any of its Subsidiaries or any trustee of the Company or
any of its Subsidiaries under any worker’s compensation
policy or other contract, policy, procedure, or staff handbook,
including any claim for unfair dismissal, unlawful discrimination,
breach of contract or redundancy pay. Except with respect to any
liabilities by virtue of law, Section 3.22(i) of the
Sellers’ Disclosure Schedule lists all contractual
liabilities of the Company to any Employee or Independent
Contractor that have resulted from the termination by the Company
or any of its Subsidiaries of such Employee’s employment or
provision of services, a change of control of the Company, or a
combination thereof. To the Knowledge of the Sellers, neither the
Company nor any of its Subsidiaries has direct or indirect
liability with respect to any misclassification of any person as an
independent contractor rather than as an employee, or with respect
to any employee leased from another employer.
(j) Labor . No
work stoppage, slowdown or labor strike against the Company or any
of its Subsidiaries is pending, or to the Knowledge of the Sellers,
threatened, or reasonably
-41-
anticipated. Neither the Sellers nor the
Company has been informed, verbally or in writing, by any labor
union or employee of any activities or proceedings of any labor
union to establish a works council or of any other significant
activities or proceedings to organize any employees. No works
council has ever been established with the Company’s German
Subsidiary since its foundation. There are no actions, suits,
claims, labor disputes or grievances pending or, to the Knowledge
of the Sellers, threatened in writing relating to any labor matters
involving any Employee, including charges of unfair labor
practices. Neither the Company nor any of its Subsidiaries has
engaged in any unfair labor practices within the meaning of
applicable law. Neither the Company nor any of its Subsidiaries is
presently, nor have they been in the past, a party to, or bound by,
any collective bargaining agreement, workforce agreement, union
recognition agreement or other union contract with respect to
employees, and no collective bargaining agreement, workforce
agreement, union recognition agreement nor other union contract is
being negotiated by the Company or any of its Subsidiaries. With
respect to U.S. Employees only, within the past year, neither the
Company nor any of its Subsidiaries has incurred any liability or
obligation under WARN or any similar state or local law that
remains unsatisfied, and no terminations prior to the Closing shall
result in unsatisfied liability or obligation under WARN or any
similar state or local law.
(k) No Interference or
Conflict . To the Knowledge of the Sellers, no Company
Shareholder, director, officer, Employee or consultant of the
Company or any of its Subsidiaries is obligated under any Contract
or agreement or subject to any judgment, decree, or order of any
court or administrative agency that would interfere with such
person’s efforts to promote the interests of the Company or
any of its Subsidiaries or that would interfere with the business
of the Company or any of its Subsidiaries. Neither the execution
nor delivery of this Agreement, nor the carrying on of the business
of the Company or any of its Subsidiaries as presently conducted
nor any activity of such Senior Managers, directors, employees or
consultants in connection with the carrying on of the business of
the Company or any of its Subsidiaries as presently conducted will,
to the Knowledge of the Sellers, conflict with or result in a
breach of the terms, conditions, or provisions of, or constitute a
default under, any Contract or agreement under which any of such
Senior Managers, directors, employees, or consultants is now
bound.
(l) Former Employees
and Former Independent Contractors . There are no
liabilities with respect to any former employees or former
Independent Contractors of the Company or any of its Subsidiaries
with respect to any Company Employee Plan.
3.23 Insurance
. Section 3.23 of the Sellers’ Disclosure
Schedule lists all insurance policies and fidelity bonds covering
the assets, business, equipment, properties, operations, employees,
Senior Managers and directors of the Company and its Subsidiaries,
including the type of coverage, the carrier, the amount of
coverage, the term and the annual premiums of such policies. There
is no claim by the Company or any of its Subsidiaries pending under
any of such policies or bonds as to which coverage has been
questioned, denied or disputed or that the Company or any of its
Subsidiaries has a reason to believe will be denied or disputed by
the underwriters of such policies or bonds. In addition, there is
no pending claim of which its total value (inclusive of defense
expenses) will exceed the policy limits. All premiums due and
payable under all such policies and bonds have been paid (or if
installment payments are due, will be paid if incurred
prior
-42-
to the Closing Date), and the Company
and its Subsidiaries are otherwise in material compliance with the
terms of such policies and bonds (or other policies and bonds
providing substantially similar insurance coverage). Such policies
and bonds (or other policies and bonds providing substantially
similar coverage) have been in effect for the past five years and
remain in full force and effect. Neither the Sellers nor the
Company has any Knowledge or reasonable belief of threatened
termination of, or premium increase with respect to, any of such
policies. None of the Company or any of its Subsidiaries has ever
maintained, established, sponsored, participated in or contributed
to any self-insurance plan.
3.24 Compliance with
Laws . The Company and its Subsidiaries have complied in
all material respects with, are not in material violation of, and
have not received any material notices of violation with respect
to, any foreign, federal, state or local statute, law or regulation
applicable to the Company, its Subsidiaries or their respective
assets or properties.
3.25 Export Control
Laws . The Company and its Subsidiaries have at all times
conducted its export transactions in accordance with all applicable
import/export and re-export controls in countries in which the
Company or any of its Subsidiaries conduct business or to whose
laws any of them are subject. Without limiting the
foregoing:
(a) The Company’s and
its Subsidiaries’ business as previously and currently
conducted, does not require the Company or any of its Subsidiaries
to obtain any export licenses, license exceptions and other
consents, notices, waivers, approvals, orders, authorizations,
registrations, declarations, classifications and filings with any
Governmental Entity in connection with the export and re-export or
licensing of products, services, software and technologies
including any Company Products or Company Intellectual Property
(“ Export Approvals ”);
(b) There are no actions,
conditions or circumstances pertaining to the Company’s or
any of its Subsidiaries’ export transactions that may give
rise to any future claims; and
(c) Neither the Company nor
any of its Subsidiaries engage or have agreed to engage, in any
boycott activities with respect to any country.
3.26 Anti-Bribery Law
Compliance . Neither the Company nor any of its
Subsidiaries (including any of their respective Senior Managers,
directors, agents, employees or other Person associated with or
acting on their behalf) has, directly or indirectly, taken any
action which would cause it to be in violation of any applicable
anti-bribery laws or regulations in countries in which the Company
or any of its Subsidiaries conducts business, used any corporate
funds for contributions, gifts, entertainment or other expenses
relating to political activity, made, offered or authorized any
payment to foreign or domestic government officials or employees,
whether directly or indirectly, or made, offered or authorized any
bribe, rebate, payoff, influence payment, kickback or other similar
payment, whether directly or indirectly.
-43-
3.27 Substantial
Customers and Suppliers .
(a)
Section 3.27(a) of the Sellers’ Disclosure
Schedule lists customers or licensees of the Company and its
Subsidiaries the agreements with whom have individually resulted in
revenues or bookings of more than two (2) percent of total
customer revenues or bookings in such periods (X) for the
twelve (12) month period ended December 31, 2006 and
(Y) for the six (6) month period ended June 30,
2007.
(b)
Section 3.27(b) of the Sellers’ Disclosure
Schedule lists the 10 largest suppliers (including third
parties that have licensed Intellectual Property Rights to the
Company or any of its Subsidiaries) of the Company and its
Subsidiaries on the basis of cost of goods, licenses or services
purchased (X) for the twelve (12) month period ended
December 31, 2006 and (Y) for the six (6) month
period ended June 30, 2007.
(c) As of the date of this
Agreement, no such customer or supplier has (i) ceased or
materially reduced its purchases from or sales or provision of
services to the Company or any of its Subsidiaries,
(ii) threatened in writing to cease or materially reduce such
purchases or sales or provision of services or (iii) to the
Knowledge of the Sellers, been threatened with bankruptcy or
insolvency.
3.28 Banks and
Brokerage Accounts . Section 3.28 of the
Sellers’ Disclosure Schedule sets forth (i) a true and
complete list of the names and locations of all banks, trust
companies, securities brokers and other financial institutions at
which the Company and any of its Subsidiaries have an account or a
safe deposit box or maintain a banking, custodial, trading or other
similar relationship; (ii) a true and complete list and
description of each such account, box and relationship, indicating
in each case the account number and the names of the respective
Senior Managers, employees, agents or other similar representatives
of the Company and any of its Subsidiaries having signatory power
with respect thereto; and (iii) a list of each investment
asset, the name of the record and beneficial owner thereof, the
location of the certificates, if any, therefor, the maturity date,
if any, and any stock or bond powers or other authority for
transfer granted with respect thereto.
3.29 Complete Copies of
Materials . The Sellers have caused the Company to
deliver true and complete copies of each Contract and each other
document listed on the Sellers’ Disclosure
Schedule.
3.30 Representations
Complete . None of the representations or warranties
made by the Sellers (as modified by the Sellers’ Disclosure
Schedule) in this Agreement, and none of the statements made in any
exhibit, schedule or certificate furnished by the Sellers pursuant
to this Agreement contains, or will contain as of the Closing, any
untrue statement of a material fact, or omits or will omit as of
the Closing to state any material fact necessary in or
|